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Christopher Michael Elitt, PhD 
University of Pittsburgh, 2006
 
Chronic pain is a major clinical problem.  Target-derived growth factors have been implicated in 
the initiation and maintenance of persistent pain states.  Artemin, a member of the glial cell line-
derived neurotrophic factor (GDNF) family, binds to its GPI-anchored receptor, GFRα3, and 
initates intracellular signaling via the tyrosine kinase, Ret.  Expression of the GFRα3 receptor is 
largely restricted to the peripheral nervous system and is found in a subpopulation of nociceptive 
sensory neurons of the dorsal root and trigeminal ganglia (DRG & TG) that coexpress the Ret 
and TrkA receptor tyrosine kinases and the thermosensitive channel TRPV1.   To investigate the 
role of artemin in regulating nociceptor properties and function, we isolated transgenic mice that 
overexpress artemin in keratinized tissues (ART-OE).  Expression of artemin increased DRG 
neuron number, confirming the survival promoting effects of artemin.  In addition, ART-OE 
mice had increased mRNA encoding GFRα3, TrkA, TRPV1 and the putative noxious cold and 
mustard oil detecting channel, TRPA1.  Immunolabeling showed that nearly all GFRα3-positive 
neurons expressed TRPV1 and most of these neurons were also TRPA1-positive. Somas of 
GFRα3/TRPV1-positive neurons in the ART-OE mice were hypertrophied and there was 
increased staining for these proteins in the periphery.  Interestingly, increases in TRPV1 and 
TRPA1 mRNA were more robust in TG than DRG.  Because of these differential effects, lingual 
afferents innervating the heavily keratinized tongue were also examined.  Retrogradely-labeled 
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lingual afferents from ART-OE tongues showed an increased percentage of GFRα3- and 
TRPV1-positive neurons.  Behavior analysis showed that these anatomical changes were 
correlated with increased sensitivity to noxious heat, noxious cold, capsaicin and mustard oil 
applied to the hindpaw, as well as oral sensitivity to capsaicin and mustard oil placed in the 
drinking water of these mice.  Functional analysis of dissociated sensory neurons using calcium 
imaging showed hypersensitivity to capsaicin and mustard oil in trigeminal neurons isolated 
from ART-OE mice, and even greater sensitivity in the lingual subpopulation.  Taken together, 
these results indicate that artemin promotes the survival and modulates functional properties of a 
select population of TRPV1- and TRPA1-positive nociceptors critical for the detection of 
noxious thermal and chemical stimuli in both cutaneous and lingual systems.   
. 
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1.0  INTRODUCTION 
1.1 THE PAIN PATHWAY AND TYPES OF CHRONIC PAIN 
 Chronic pain is a major clinical problem that has significant physical, emotional and 
economic costs.  According to estimates by the American Pain Society, nearly 50 million people 
are partially or totally disabled by pain and 45% of all Americans seek care for persistent pain at 
some point in their lives.  Current therapies for chronic pain consist primarily of non steroidal 
anti-inflammatory drugs (NSAIDS) or opioids, both of which are relatively non-specific drugs 
for the diverse types of persistent pain and have many unpleasant side effects.   It is not 
surprising, therefore, that nearly two-thirds of chronic pain patients report inadequate pain 
control (http://www.painineurope.com).  Developing new treatments for chronic pain requires 
understanding nociceptive sensory neurons and determining molecular changes in these neurons 
that may contribute to persistent pain states. 
Pain sensations from the body and head are transmitted from the periphery by neurons 
located in dorsal root (DRG) and trigeminal ganglia (TG), respectively.  These pseudounipolar 
neurons contain a peripheral process that innervates the target (skin, tongue, face, etc.) and a 
central process that synapses on second order neurons in the superficial dorsal horn of the spinal 
cord (or analogous area in the brainstem for TG neurons) (Figure 1).  Dorsal horn neurons 
project to the thalamus or brainstem where third order neurons relay pain signals to the cortex.  
Our experiments focus on the first neuron in this pathway, the primary afferent. 
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Figure 1. Diagram of the pain pathway. 
It takes three neurons to convey pain signals from the periphery to the cerebral cortex.  Primary afferents relay 
nociceptive information to the central nervous system by synapsing on second order neurons of the superficial dorsal 
horn in the spinal cord (or equivalent medullary dorsal horn of the brainstem).  These second order neurons project 
to third order neurons in the thalamus which ultimately convey the signals to the cerebral cortex.    
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  Primary afferents that detect damaging or potentially damaging tissue stimuli are called 
nociceptors.  These neurons are primarily small diameter unmyelinated C-fibers and lightly 
myelinated Aδ fibers, although some Aβ fibers also function as nociceptors (Djouhri and 
Lawson, 2004).  Most of the time these specialized sensory neurons serve a protective function 
to prevent tissue injury when noxious stimuli are encountered (e.g. when tissue is being burned 
by accidentally touching a scalding hot stove or when frostbite is imminent after throwing 
snowballs with bare hands).  Many plants have also evolved to contain pungent chemicals that 
can activate these same nociceptors, producing acute pain in the oral cavities of plant consuming 
animals.  Some of these chemicals include: capsaicin, found in chili peppers; allyl 
isothiocyanate, found in mustard oil; allicin, found in garlic; and cinnamaldehyde, found in 
cinnamon.   All of these examples illustrate potential adequate stimuli for nociceptors during 
acute pain states.   
 Chronic pain, on the other hand, is pathologic and serves no obvious protective purpose. 
Frequently, chronic pain is divided into inflammatory pain, triggered by increased nociceptive 
input from inflamed or injured tissue, and neuropathic pain, triggered by changes in injured 
nerves or adjacent uninjured fibers.  In both types of pain, pain sensations are initiated 
peripherally, by the primary afferent.  However, central mechanisms also play a role in the 
maintenance of chronic pain conditions as indicated by the contribution of descending input from 
the rostral ventral medulla to the maintenance of both inflammatory and neuropathic pain 
(reviewed in (Porreca et al., 2002)). 
While the relative contributions of peripheral vs. central mechanisms leading to 
sensitized pain circuits is complex, without primary afferent input persistent pain states are rarely 
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initiated (an exception is stroke-induced pain).  Thus, in recent years many studies have 
examined molecular changes in the primary afferent that initiate peripheral sensitization in 
primary afferents.  Target-derived growth factors such as nerve growth factor (NGF) and glial 
cell line-derived neurotrophic factor (GDNF) have been implicated in this sensitization process.  
1.2 SENSORY NEURON DEVELOPMENT  
 During development, sensory neurons innervating target tissues depend on limited 
quantities of target-derived growth factors for survival (The Neurotrophic Hypothesis) (reviewed 
in (Davies, 1996)).  This competition leads to programmed cell death such that nearly 50% of 
sensory neurons die via apoptosis during development.  Thus, according to the neurotrophic 
hypothesis, artificially increasing the concentration of a target-derived growth factor at critical 
times during development could selectively rescue neurons from apoptotic cell death.  Our 
laboratories have previously validated this theory using the K14 keratin promoter to drive 
transgene expression of numerous growth factors, such as NGF (Albers et al., 1994), selectively 
in keratinized targets.  This approach has been extended to a member of the GDNF family, 
artemin, in this study.   
 Like all sensory neurons, early in embryonic development (E11-E16) nociceptors are 
dependent on the neurotrophin NGF.  This dependency is highlighted by the complete absence of 
nociceptors in mice lacking NGF or its receptor tyrosine kinase, TrkA (Crowley et al., 1994; 
Smeyne et al., 1994; Silos-Santiago et al., 1995).  However, this dependency switches late in 
development such that approximately 50% of nociceptors begin to express the receptor tyrosine 
kinase, Ret, and become responsive to members of the GDNF family (Molliver and Snider, 
1997).   
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1.3 GLIAL CELL LINED-DERIVED NEUROTROPHIC FACTOR (GDNF) FAMILY 
MEMBERS 
The GDNF family ligands (GFLs) consist of GDNF, neurturin, artemin and persephin.  
Each of the GFLs binds a preferred GDNF-family receptor-α (GFRα) that is coupled to the 
plasma membrane via a glycosyl phosphatidylinositol (GPI) anchor (reviewed in (Airaksinen and 
Saarma, 2002)).  GDNF preferentially binds GFRα1, neurturin preferentially binds GFRα2, 
artemin preferentially binds GFRα3 and persephin preferentially binds GFRα4 (Figure 2).  
Persephin does not act as a neurotrophic factor in the PNS (Milbrandt et al., 1998) and will not 
be discussed further.  While GDNF and neurturin can also bind GFRα2 and GFRα1 (Jing et al., 
1997), respectively, only artemin can activate GFRα3 (Baloh et al., 1998b).   Upon GFL binding, 
the GFL/GFRα complex binds to the extracellular domain of the receptor tyrosine kinase (Ret).  
This binding triggers autophosphorylation of the intracellular tyrosine residues which initiate a 
host of downstream intracellular signaling cascades.  The phosphotyrosine residues can activate 
various signaling pathways including RAS/ERK, PI3K/AKT, p38MAPK and JNK (reviewed in 
(Takahashi, 2001)), important for a variety of cell processes including survival, proliferation, and 
neurite outgrowth.  In addition, the GPI-linked proteins cluster into lipid rafts in the plasma 
membrane and this location is critical for Ret signaling (Tansey et al., 2000). 
1.3.1 GDNF 
GDNF was purified from a rat glial cell line and shown to support embryonic 
dopaminergic midbrain neurons in vitro (Lin et al., 1993), creating great excitement that it might 
be used to treat neurodegenerative diseases, like Parkinson’s Disease.  In the peripheral nervous 
system, GFRα1-positive sensory neurons bind the lectin IB4, are peptide poor, and some appear 
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Figure 2. GDNF family members and their GFRα receptors. 
The GDNF family members consist of GDNF, neurturin and artemin (persephin, not shown, is also a member of the 
GDNF family and bind GFRα4).  Each GDNF family ligand (GFL) binds a preferred GFRα co-receptor that is 
coupled to the plasma membrane by a glycosyl-phosphatidyl inositol(GPI)-linked anchor.  The GFRαs are coupled 
to the receptor tyrosine kinase, RET, which via phosphorylation, initiates intracellular signaling.  There is some 
cross talk between receptors as indicated for GDNF and neurturin, although GFRα3 appears to be specific for 
artemin. 
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to be mechanoreceptors (Silverman and Kruger, 1988; Molliver and Snider, 1997; Bennett et al., 
1998; Albers et al., 2006).   Mice lacking GDNF have a 23% loss of DRG neurons at postnatal 
day 0, fail to develop kidneys and have deficits in the enteric nervous system (Moore et al., 
1996).  In addition, mice overexpressing GDNF in the skin have a 27% increase in Ret-positive, 
IB4-binding DRG neurons (Zwick et al., 2002).  
1.3.2 Neurturin 
Neurturin was initially purified and cloned from the conditioned media of CHO cells as a 
factor which supported the long term survival of superior cervical ganglion sympathetic neurons, 
nodose ganglia sensory neurons and a small population of dorsal root ganglia sensory neurons in 
culture (Kotzbauer et al., 1996).  Mice lacking neurturin have fewer GFRα2-positive neurons and 
mice lacking neurturin (Heuckeroth et al., 1999) or GFRα2 have defects in innervation to the 
skin, enteric nervous system and parasympathetic innervation of glands (Heuckeroth et al., 1999; 
Rossi et al., 1999; Lindfors et al., 2006).   In addition, mice lacking GFRα2 exhibit reduced heat 
currents in IB4-positive neurons, but do not lose myelinated or unmyelinated fibers in the 
saphenous nerve, suggesting that no cutaneous GFRα2-positive neurons were lost in these mice 
(Stucky et al., 2002). 
1.3.3 Artemin 
 Following the discovery of neurturin and the cloning of its preferred receptor, GFRα2, a 
third member of the GFRα family, GFRα3, was cloned based on sequence homology to the other 
GFRαs (Jing et al., 1997; Widenfalk et al., 1998; Worby et al., 1998).  In situ hybridization 
signals for GFRα3 are found in developing (E14 to P7) dorsal root, trigeminal and sympathetic 
ganglia, as well as in developing nerves and Schwann cells (Widenfalk et al., 1998).    In contrast 
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to GFRα1 and GFRα2, most studies indicate that GFRα3 is not expressed in the central nervous 
system in developing or adult mice (Baloh et al., 1998a; Widenfalk et al., 1998).  However, one 
group reported detectable expression of GFRα3 in mouse brain at E12 and E15 using RNA 
protection assays, but expression was quickly downregulated to undetectable levels by P3 
(Naveilhan et al., 1998).    GFRα3 is, however, expressed in the developing disgestive tract and 
the urogential system (Baloh et al., 1998a; Worby et al., 1998).    
 In the adult mouse, GFRα3 expression becomes restricted primarily to neuronal tissues 
(dorsal root and cranial ganglia), although one group showed small amounts of GFRα3 mRNA 
(relative to trigeminal ganglia) in pituitary gland, thymus, lung and duodenum (Naveilhan et al., 
1998).  All studies indicate that, by far, the highest level of expression of GFRα3 mRNA is in 
cranial and dorsal root ganglia (Baloh et al., 1998a; Naveilhan et al., 1998).  Moreover, in the 
adult, only a subpopulation of dorsal root and trigeminal neurons express GFRα3 (Baloh et al., 
1998a), and this subpopulation appears to be distinct from the GFRα1 and GFRα2 populations 
(Naveilhan et al., 1998).   From these studies characterizing the expression patterns of GFRα3 
mRNA, it also became apparent that none of the known ligands in the GDNF family could 
initiate Ret signaling via this receptor (Jing et al., 1997; Baloh et al., 1998a), leading to the 
search for the ligand for GFRα3.    
 Artemin was cloned shortly after the discovery of GFRα3 based on homology to the other 
members of the GDNF family (Baloh et al., 1998b).  In this initial report, artemin mRNA was 
found to be expressed at low levels in many adult peripheral tissues, the highest being in the 
pituitary gland, placenta and trachea.  In addition, fetal lung and fetal kidney expressed artemin 
mRNA and very low levels of expression were detected in the fetal and adult brain.    In E14 rats, 
the developing DRG nerve roots robustly expressed artemin mRNA, but expression was absent 
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in the cell bodies of DRG neurons, suggesting that Schwann cells of the developing nerve were 
the source of artemin mRNA (Baloh et al., 1998b).  More recent studies indicate that artemin is 
expressed in the smooth muscle of the vasculature (Honma et al., 2002), hippocampal neurons 
(Quartu et al., 2005), carotid body cells (Leitner et al., 2005) and gut tissues (Lucini et al., 2005).  
There are at least 5 differently spliced mRNA variants of artemin, only two of which produce 
functional artemin protein (Masure et al., 1999).  Therefore, it is not surprising that mRNA 
expression pattern do not perfectly match artemin protein studies.  However, it is clear that 
artemin protein is expressed by a variety of target tissues and therefore could act a survival factor 
for neurons innervating these structures and/or contribute to the homeostasis of adult neurons in 
these targets.  
 Artemin supports the survival of a subset of postnatal dorsal root and trigeminal ganglia 
sensory neurons (Baloh et al., 1998b; Baudet et al., 2000) and is required for migration of 
sympathetic precusors (Nishino et al., 1999).  In the DRG, artemin promotes the in vitro survival 
of as many or more neurons than GDNF or neurturin and increasing doses of artemin increases 
the survivial of DRG neurons (Baloh et al., 1998b).  Interestingly, in the P1 trigeminal ganglia, 
recombinant artemin promotes significantly greater survival of neurons compared to GDNF, 
neurturin or NGF (Baloh et al., 1998b), suggesting that trigeminal neurons may be particularly 
sensitive to artemin concentrations during development.  Similarly, conditioned media from 
mouse cells transfected with artemin cDNA only promoted the survival of 5% of embryonic 
DRG neurons from E12 and E16 embryos but promoted survival of 20% and 72% of P0 and P15 
neurons, respectively (Baudet et al., 2000).  Therefore, artemin appears to support the survival of 
a subpopulation of postnatal sensory neurons.  
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 Until very recently, few studies have examined GFRα3 or artemin protein expression, 
due to the absence of antibodies for these ligands.  Orozco et al. produced an anti-mouse GFRα3 
antibody and examined co-localization with various markers of nociceptors (Orozco et al., 2001).  
In adult mouse L5 DRG nearly 20% of neurons are positive for GFRα3 and nearly all of those 
cells (97.5%) co-localize with peripherin, a marker of small diameter neurons that primarily give 
rise to unmyelinated fibers.  The majority of the GFRα3-positive neurons also express calcitonin 
gene related peptide (CGRP) (70%), Ret (82%) and TrkA (80%), while a smaller percentage 
bind the lectin IB4 (30%).  This suggests that most artemin responsive cells are IB4-negative 
neurons and respond to NGF.   This is in contrast to GDNF and neurturin which primarily 
support non-peptidergic, IB4-binding neurons (Baloh et al., 1997).    However, the most striking 
finding from this immunocytochemical characterization was that virtually all (99%) of GFRα3-
positive neurons also express the capsaicin receptor, TRPV1, suggesting that the artemin 
responsive population of neurons were of great importance for pain signaling.  Thus, there is 
considerable evidence that GFRα3-positive neurons are a unique subpopulation of sensory 
neurons with many nociceptive characteristics.   
1.4 TRP CHANNELS 
 For many years, neurons that responded to noxious thermal, chemical or mechanical 
stimuli (nociceptors) were identified in part by their sensitivity to the “hot” or “spicy” ingredient 
in chili peppers, capsaicin.  Application of capsaicin to the skin leads to a psychophysical 
sensation of burning pain (LaMotte et al., 1991).  This sensation results from excitation of 
nociceptive neuron terminals and their local release of inflammatory mediators (CGRP and 
Substance P).  High doses of capsaicin in the neonatal period can ablate nociceptive neurons 
(Jancso et al., 1977) and repeated applications of capsaicin in the adult produce desensitization of 
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nociceptors (Jancso et al., 1967; Jancso, 1992).  This desensitization is the basis for over the 
counter capsaicin creams used to treat a variety of pain disorders (back pain, diabetic neuropathy, 
rheumatoid arthritis, etc).   
 The molecular transducer in nociceptors that produces these effects upon capsaicin 
application was unknown until Caterina et al. cloned the capsaicin receptor (Caterina et al., 
1997).  They used a functional screening strategy by isolating candidate cDNA clones from DRG 
mRNA, injecting them into HEK293 cells and then assaying for capsaicin sensitivity using Fura-
2 calcium imaging.  The newly cloned cDNA was initially named vanilloid receptor subtype 1, 
based on its responsiveness to members of the vanilloid family, capsaicin and resiniferatoxin.  
TRPV1 (formerly named VR1) contains six transmembrane domains with a short hydrophobic 
stretch between transmembrane regions 5 and 6 as well as three ankyrin repeat domains on the 
amino terminus (Figure 3).  It is also a distant relative of Drosophila transient receptor potential 
(TRP) ion channels, which mediate depolarization of photoreceptors in the fly (Montell and 
Rubin, 1989).  Initial characterization showed that in addition to capsaicin, TRPV1 also responds 
to noxious heat (<42°) and acid (protons).  A variety of related channels have since been cloned 
and are hypothesized to play important roles in thermosensation (reviewed in (Jordt et al., 2003; 
Dhaka et al., 2006)).  TRPV2 has been identified as an additional noxious heat channel, 
responding to temperatures >52°C in heterologous systems, whereas TRPV3 and TRPV4 
respond to warmer temperatures (in the range of 27-39°C).  In addition, two TRP channels that 
detect cold stimuli have also been identified.  TRPM8 responds to innocuous cool temperatures 
(~8-28°C) and menthol whereas TRPA1 is activated by noxious cold temperatures <17°C as well  
as mustard oil, cinnamon oil and bradykinin (Figure 3).  Thus, at least in heterologous systems  
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Figure 3. Thermosensitive TRP Channels. 
The TRP family of cation channels contain six transmembrane domains with a hydrophobic region between domains 
5 and 6.  Different members of this family have been proposed to mediate flux of cations in response to different 
thermal stimuli such as noxious cold (TRPA1), innocuous cooling (TRPM8), warming (TRPV3, TRPV1) and 
noxious heat (TRPV1, TRPV2).  In addition, some members of TRP family respond to chemicals that elicit burning 
or cooling/cold sensation in humans and animals.  Adapted from Jordt et al., 2003. 
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TRPV1, TRPV2 and TRPA1 respond to noxious temperatures and/or chemicals, whereas 
TRPV3, TRPV4 and TRPM8 can respond to non-noxious thermal stimuli.   
1.4.1 TRPV1  
 TRPV1 is a nonselective cation channel that is gated by noxious heat (>43°C), protons, 
and vanilloid compounds (capsaicin, resiniferatoxin) (Caterina and Julius, 2001).  TRPV1 is 
localized to a subset of small diameter nociceptors in trigeminal and dorsal root ganglia (Caterina 
et al., 1997). In mouse, TRPV1 is mainly expressed in IB4-negative, peptidergic neurons (Zwick 
et al., 2002).  In behavioral testing, TRPV1-/- mice have normal mechanical thresholds and 
relatively normal thermal thresholds (Caterina et al., 2000; Davis et al., 2000).  In contrast, in 
cultured DRG neurons from the TRPV1-/- knockout animals, the electrophysiologic response to 
noxious heat is absent (Caterina et al., 2000; Davis et al., 2000).  However, in an ex vivo 
physiological preparation where skin, DRG and spinal cord are maintained intact in artificial 
CSF, the response to noxious heat in TRPV1-/- mice does not differ from wildtype mice 
(Woodbury et al., 2004).  Therefore, in contrast to initial reports, TRPV1 does not appear to be 
necessary for the detection of noxious heat in normal animals.   
However, there is considerable evidence that TRPV1 is required for inflammation-
induced heat hyperalgesia.  Wildtype mice injected with carrageenan or CFA (Complete 
Freund’s Adjuvant) become inflamed and develop robust thermal and mechanical hyperalgesia 
whereas TRPV1 knockout mice do not experience thermal hyperalgesia following induction of 
inflammation (Caterina et al., 2000; Davis et al., 2000).  Various laboratories have shown that 
inflammation or injury increases TRPV1 protein or mRNA (Tohda et al., 2001; Ji et al., 2002; 
Amaya et al., 2003; Molliver et al., 2005).  In addition to increased synthesis of TRPV1, specific 
inflammatory mediators can sensitize TRPV1.  For example pro-algesic substances released 
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during inflammation such as ATP (Moriyama et al., 2003) and bradykinin (Chuang et al., 2001; 
Sugiura et al., 2002) have been shown to sensitize TRPV1 and this sensitization is absent in 
TRPV1-/- knockouts.  In addition, neurotrophic factors such as NGF are increased following 
inflammation (Donnerer et al., 1992) and can sensitize nociceptors by modulating TRPV1 
(Chuang et al., 2001; Galoyan et al., 2003).  Taken together, these studies indicate that TRPV1 is 
part of a common signaling pathway used by different inflammatory modulators to produce 
hypersensitivity.   
1.4.2 TRPA1 
The role of TRPA1 in sensory neuron thermal and chemical detection remains 
controversial.  The initial paper identifying TRPA1 (ANKTM1) showed that TRPA1 mRNA is 
expressed in a small subpopulation of DRG (3.6%) and trigeminal neurons, and almost all of 
these neurons contain TRPV1 (97%) and CGRP (97%) (Story et al., 2003).  These authors 
propose that this population of afferents is distinct from those expressing the “cooling” receptor 
TRPM8.  Specifically, TRPA1 expressing CHO or HEK cells have large calcium transients in 
response to low temperature (10°C), respond at lower temperatures than cells expressing 
TRPM8, and do not respond to heat, menthol, or hypotonic solutions.  Analysis of adult DRG 
neurons (without NGF in the media) indicated that there are two populations of cold sensitive 
neurons, one that responds to menthol and cool temperatures with a threshold of activation of 
24°C, and another group that responds to colder temperatures with a threshold of activation of 
15°C but does not respond to menthol (Story et al., 2003).  These findings support the hypothesis 
that TRPM8-expressing neurons respond to cool temperatures while TRPA1-expressing neurons 
respond to noxious cold temperatures. 
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A more general role for TRPA1 in pain detection has come from studies showing that 
plant-derived compounds (allyl isothiocyanates from mustard oil, cinnamaldehyde from 
cinnamon, allicin from garlic and Δ9-tetrahydrocannabinol (THC) from marijuana) can also 
activate the channel (Bandell et al., 2004; Jordt et al., 2004; Macpherson et al., 2006).  In 
addition, bradykinin, an endogenous inflammatory peptide acting via a G-protein coupled 
receptor, activates TRPA1 (Bandell et al., 2004), suggesting a role for TRPA1 in tissue injury 
and inflammation.  Interestingly, recent evidence shows that the fly homolog of mammalian 
TRPA1, painless, is essential for isothiocyanate avoidance in Drosophilia (Al-Anzi et al., 2006), 
indicating that TRPA1 is an evolutionally conserved pathway for detecting and avoiding noxious 
chemicals.   
Many of the studies characterizing TRPA1 activation in response to pungent chemicals 
also re-examined the expression patterns of TRPA1 and cold responses in dissociated cells, with 
variable results.  In newborn rats, Jordt et al. detected TRPA1 mRNA in 20% of trigeminal 
neurons and found calcium responses to 20μM mustard oil in 35% of cells (all of which are also 
responsive to 1μM capsaicin) (Jordt et al., 2004).  However, almost none (4%) of the mustard oil 
sensitive cells responded to noxious cold (5°C) and those that did also responded to menthol 
(Jordt et al., 2004).    Other laboratories report much wider distributions of TRPA1 mRNA in 
mouse TG (37%) and DRG (57%) and have not found cold responses (27°C→15°C) in HEK 
cells transfected with TRPA1 (Nagata et al., 2005).   
In addition to the first report of noxious cold activation of TRPA1 (Story et al., 2003), 
four other laboratories have confirmed this finding in heterologous systems (reviewed in (Dhaka 
et al., 2006)).  Reid and colleagues contend that the difficulty in finding TRPA1-like responses in 
DRG neurons (Babes et al., 2004; Jordt et al., 2004), may reflect differences in the activation rate 
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of the channel in native and heterologous systems (Reid, 2005).  They found that human and 
mouse clones are activated rapidly and strongly by cold (12°C), but native rat DRG neurons are 
activated very slowly in response to cold, with a delay of up to a 1 min, suggesting the possibility 
that cold activation of TRPA1 in native neurons is actively inhibited.  They contend that release 
of this inhibition by an endogenous mediator such as bradykinin (Bandell et al., 2004) might 
permit TRPA1 to respond to cold only in damaged or inflamed tissue (Reid, 2005).    
Recent work in inflammatory and neuropathic pain models supports this hypothesis.  
Following CFA injection in rats, TRPA1 mRNA expression increases from 32% of DRG 
neurons prior to injection to 44% 1 day post-CFA, 42% 3 days post-CFA and gradually returns 
to normal by day 7 (Obata et al., 2005).  These changes parallel the time course of cold 
hyperalgesia observed in behavioral testing of these rats.  This upregulation can be inhibited by 
anti-NGF antibody injection or by a p38 MAPK inhibitor and can be induced by intrathecal 
injection of NGF, but not GDNF.  Similar increases in TRPA1 mRNA were seen following L5 
spinal nerve ligation (SNL) in the spared L4 DRG (Obata et al., 2005; Katsura et al., 2006b).  In 
both the inflammatory (CFA) and neuropathic (SNL) pain models, both TRPA1 induction and 
cold hyperalgesia could be prevented by treatment with TRPA1 antisense oligodeoxynucleotides 
(Obata et al., 2005; Katsura et al., 2006b).  These results provide further support for the 
hypothesis that TRPA1 is essential for cold hyperalgesia seen following inflammation or injury, 
remarkably similar to the role of TRPV1 in heat hyperalgesia after inflammation. 
Two groups recently disrupted the TRPA1 gene by deleting the pore region of the 
channel (Bautista et al., 2006; Kwan et al., 2006) and tested sensitivity to thermal, mechanical 
and chemical stimuli.  Whereas Kwan et al. showed a substantially reduced number of mustard 
oil-responsive cells using calcium imaging and reduced behavioral sensitivity to oral or injected 
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mustard oil, Bautista et al. showed the complete absence of mustard oil responses behaviorally or 
in dissociated cells.  Curiously, the remaining mustard oil responsive cells seen in Kwan study 
were in capsaicin insensitive cells, suggesting that there may be another mustard oil receptor in a 
small population of afferents.  Most interesting, however, were the conflicting results regarding 
the behavioral responses to noxious cold.  Bautista et al. found no difference in latency to 
hindpaw lift on a cold plate (0°C) and no difference in flinches/min in the acetone test (another 
measure of cold responsiveness where chilled acetone is dripped onto the skin) between wildtype 
and TRPA1-/- mice.  However, Kwan et al. found decreases in the number of hindpaw lifts over 
five minutes in the cold plate test (0°C) (particularly in female mice) and decreased duration of 
paw shake in the acetone test.  Thus, the method of measuring responses and the gender of the 
mice used may have contributed to the conflicting results in these two papers.  Further study 
regarding the role of TRPA1 in the detection of noxious cold is clearly necessary.   
Taken together, these studies suggest that TRPA1 is a polymodal sensor for noxious 
stimuli and afferents containing both TRPV1 and TRPA1 may be critically important in pain 
signaling, particularly during inflammation or injury.   
1.5 LINGUAL AFFERENTS  
 Most work on the role of growth factors in regulating survival and maintenance of 
nociceptors has been done in DRG neurons.  However, for reasons that are not clear, the effects 
of alterations in epithelial-derived growth factors on trigeminal afferents are often more 
dramatic, perhaps reflecting the dense innervation of the whisker pad and oral cavity regions.  In 
addition, persistent pain involving cranial structures is of major clinical significance and is 
understudied.  Therefore, our study examined trigeminal neurons in parallel with our studies of 
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cutaneous DRG neurons, specifically focusing on lingual afferents that innervate the tongue, a 
structure that routinely contacts noxious thermal and chemical stimuli. 
1.5.1 Tongue Anatomy and Innervation 
The tongue epithelium is a highly innervated structure containing both special sensory 
(taste) and general sensory (somatic) afferents.  For the anterior 2/3 of the tongue, taste 
information is conveyed through the chorda tympani (cranial nerve VII) to the geniculate 
ganglion and general sensory information is conveyed through the lingual nerve (cranial nerve 
V) to the trigeminal ganglion.  Analogous to the cutaneous system where DRG neurons have 
both a peripheral and a central process, trigeminal neurons which innervate the tongue also have 
central projections to the brain stem trigeminal subnuclei caudalis (Vc) (medullary dorsal horn) 
(Carstens et al., 1995). 
1.5.2 Previous studies on lingual afferents 
Anatomical studies of cat lingual nerve fibers using electron microscopy showed that 
nearly 44% of fibers are unmyelinated (Holland and Robinson, 1992).  This is in contrast to 
mouse cutaneous nerves (e.g. saphenous) in which 83% are unmyelinated (Stucky et al., 1999).  
There are very few studies on the response properties of lingual afferents to thermal and 
chemical stimuli.  The most extensive study (Wang et al., 1993) showed that similar to the 
innervation of cutaneous structures, the tongue is innervated by a combination of myelinated (Aβ 
and Aδ) and unmyelinated afferents.  The Aβ fibers were all mechanoreceptive and did not 
respond to thermal or chemical stimuli.  The Aδ fibers were heterogeneous in their response 
properties with some being responsive to mechanical and chemical stimuli whereas others 
responded only to thermal stimuli or to both mechanical and thermal stimuli.  The C-fibers were 
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rare and were either high threshold mechanoreceptors or polymodal nociceptors (Wang et al., 
1993).  Other studies have classified whole lingual nerve responses to non-noxious thermal 
stimuli (Lundy and Contreras, 1995; Pittman and Contreras, 1998).  Almost no data is available 
regarding the response of lingual afferents to capsaicin and mustard oil. 
Both mustard oil and capsaicin elicit burning sensation when either is applied to the 
tongue of human subjects (Simons et al., 2003).  In addition, this study also showed that mustard 
oil exhibits self-desensitization and reciprocal cross desensitization with capsaicin (i.e. either 
ligand desensitizes responses to the other ligand).  These studies support the hypothesis that the 
tongue contains nociceptors uniquely designed to detect noxious chemical stimuli.  In addition, 
the cross desensitization raises the question as to whether the same primary afferents in the 
tongue have both TRPA1 and TRPV1 or if the two signals converge at higher levels of the pain 
pathway.     
1.5.3 Clinical Relevance of Lingual Afferents 
Dysfunction of lingual afferents leads to a variety of chronic oral pain disorders.  One 
particularly disabling oral pain disorder is Burning Mouth Syndrome (BMS), characterized by 
spontaneous burning pain typically in the tip and anterior two-thirds of the tongue.  BMS may 
affect up to 40% of post-menopausal women.  Recent evidence suggests that patients with BMS 
have small fiber sensory neuropathy (Lauria et al., 2005) which might induce sensitization of 
remaining lingual afferents and contribute to this disorder.  Although few treatments are 
available for BMS, topical (Epstein and Marcoe, 1994) and systemic capsaicin (Petruzzi et al., 
2004) provide symptomatic relief.  Despite the prevalence of chronic oral pain disorders like 
BMS, there is a paucity of data regarding the afferents that innervate these important structures. 
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1.6 GOALS OF THE DISSERATION 
Prior to my studies, the role of artemin in regulating the phenotype and function of 
nociceptors was entirely unknown.  Artemin was particularly interesting because all of the 
artemin-responsive neurons expressed TRPV1, a key molecular integrator of noxious stimuli.  A 
few studies had also shown that artemin promoted the survival of postnatal sensory neurons in 
vitro, suggesting that like other growth factors, artemin might support a select population of 
nociceptors during development.   
Just after I joined the Davis lab, Kathryn Albers’ laboratory successfully created a novel 
line of transgenic mice that overexpressed artemin selectively in keratinized tissues.  These mice 
seemed like an ideal starting point for investigating the developmental survival role of artemin 
and functional role of artemin in regulating adult responses to noxious heat.  At this point, I 
hypothesized that the ART-OE mice would have increased survival of a population of 
nociceptors that were GFRα3 and TRPV1-positive and functionally would be behaviorally 
hypersensitive to heat.   
During the initial anatomical characterization of the ART-OE mice (Chapter 3), two 
striking findings broadened my goals from simply investigating the role of artemin in modulating 
heat sensitivity (via TRPV1) in the cutaneous system.  First, in addition to increases in TRPV1, 
ART-OE mice displayed a dramatic upregulation in TRPA1, leading to the hypothesis that 
artemin might regulate responses to noxious cold and pungent chemical stimuli.  The TRPA1 
finding led to a battery of behavioral assays on cold and chemical detection (Chapter 4). Second, 
all of the changes in gene expression in the DRG were much larger in the TG, suggesting that 
artemin might differentially affect TG neurons.  While the TG projects to many regions, I 
decided to characterize lingual afferents, as the tongue is heavily keratinized, routinely contacts 
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pungent chemicals and noxious temperatures, and is understudied.  This led to anatomical 
characterization of lingual afferents in WT and ART-OE mice (Chapter 3) and additional oral 
behavioral experiments (Chapter 4).   
Finally, to examine the functional responses of nociceptors to increased concentration of 
artemin at the single cell level, I performed calcium imaging on dissociated TG neurons that 
were retrogradely labeled from the tongue.  Lingual and trigeminal afferent sensitivity to the 
ligands for TRPV1 and TRPA1 are discussed in Chapter 5.  
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2.0  METHODS 
2.1 CONSTRUCTION OF TRANSGENIC MICE 
We isolated transgenic mice that overexpress the coding portion of the artemin gene in 
basal keratinocytes of the epidermis and tongue.  Mice were generated and screened as 
previously described for other growth factor genes (Albers et al., 1994; Albers et al., 1996; 
Zwick et al., 2002). A 1100 bp fragment was PCR cloned from genomic DNA isolated from 
mouse liver using primers (5’CGAAAGCTATGGAACTGGGA3’; 
5’GATCATCCTCAGCCCAGACA3’) that encompass nucleotides of the artemin gene 
(Accession #NT039264) (Honma et al., 2002). The amplified fragment, which contains two 
intronic sequences within the artemin coding region (see Fig. 1A), was cloned into the pCR4-
TOPO vector (Invitrogen, San Jose, CA) and sequence fidelity verified by DNA sequencing in 
the University of Pittsburgh Genomics and Proteomics Core Laboratory. A purified fragment 
containing 2.3 Kb of the human K14 keratin promoter sequence, 1.1 Kb of mouse artemin DNA 
and 1.7 Kb of the human growth hormone gene containing intron/exon and polyA signal 
sequences was injected into C57Bl6J/C3H F1 hybrid fertilized oocytes. Founder lines were 
screened using slot blot assays done on DNA from tail skin using transgene specific and artemin 
specific random primed 32P-dCTP-labeled probes. Reverse transcriptase-PCR analysis of RNA 
from founder offspring backskin was used to assay the relative level of transgene expression. 
Detailed analysis was focused on the transgenic line that exhibited the highest transgene copy 
number. Primers to detect endogenous and transgenic artemin 
(5’CTCAGTCTCCTCAGCCCG3’ and 5’TCCACGGTCCTCCAGGTG3’) and transgene 
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specific primers (5’CGAGCTGATACGTTTCCCGCTTC3’ and 
5’AAGAGGGCAGCCAGTGTTTCTC3’) were used. Analyses were performed on male and 
female transgenic and wildtype mice between 2 and 6 months old kept under AAALAC 
conditions in the animal facility of the University of Pittsburgh. Animals were cared for and used 
in accordance with guidelines of the U.S. Public Health Service Policy on Humane Care and Use 
of Laboratory Animals and the NIH Guide for the Care and Use of Laboratory Animals. 
2.2 TOTAL CELL COUNTS 
The number of L4 DRG neurons and TG neurons was estimated using previously 
described methodology (Harrison et al., 2004). Wildtype (n=4) and ART-OE (n=3) mice were 
deeply anesthetized, perfused with 0.9% NaCl and ganglia collected. Ganglia were postfixed in 
4% paraformaldehyde for 30 min. Serial 8μM sections stained with cresyl violet were analyzed 
by counting neurons with visible nucleoli from at least ten equally spaced sections.  Final 
estimates of cell number were obtained from raw counts that were adjusted using a correction 
factor to account for neurons with multiple nucleoli, which theoretically could be counted more 
than once. 
2.3 TISSUE IMMUNOLABELING  
Skin, ganglia and spinal cord collected from animals perfused with saline were placed in 
30% sucrose, embedded in OCT and cut on a cryostat at 20μm thickness. Sections were fixed 
either for 10 min in -20°C acetone (GFRα3 and TRPA1 labeling) or 10 min in 4°C 4% 
paraformaldehyde (TRPV1, CGRP and IB4). The percent of neurons labeled was determined by 
comparing the number of GFRα3-positive, TRPV1-positive or both TRPV1 and GFRα3-positive 
neurons with the total number of neurons labeled with antibodies to peripherin and neurofilament 
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200, which represents nearly all neurons in the ganglia. At least 3 40X fields from a minimum of 
four nonadjacent sections were counted. Only neurons with visible nuclei were counted to avoid 
counting errors that could result from ART-OE neuron hypertrophy. A minimum of 1000 
neurons/animal were counted in at least 3 WT and 3 ART-OE mice.  Somal size was measured 
using NIH Image J software using at least 150 profiles with nuclei per animal.  Significance 
differences were determined using a Student’s t-test.  Antibodies used were rabbit anti-artemin 
(5Mg/ml; R&D systems, Minneapolis, MN), anti-TRPV1 (1:250 skin, 1:500 ganglia; Oncogene 
Research, San Diego, CA), goat anti-GFRα3 (1:80; R&D Systems, Minneapolis, MN), mouse 
anti-peripherin (1:400; Chemicon, Temecula, CA), mouse anti-neurofilament 200 (1:400; Sigma, 
St. Louis, MO), rabbit anti-calcitonin gene related peptide (CGRP, 1:1000, Sigma), rabbit anti-
TRPA1 (10 Mg/ml; a generous gift from D. Corey, Harvard University)(Corey et al., 2004).  
Isolectin B4 (IB4) conjugated to Cy3 was purchased from Molecular Probes and used at 1:200. 
Donkey anti-rabbit and donkey anti-goat secondary antibodies (Jackson ImmunoResearch 
Laboratories, West Grove, PA) were used at 1:200.  
2.4 CONFOCAL ANALYSIS OF DRG NEURONS 
Immunolabeled DRG (L3, L4, L5) sections were visualized with a Leica confocal 
microscope (Leica Microsystems; Wetzlar, Germany).  To avoid selection bias, fields for 
analysis were chosen using NF200/Peripherin immunolabeling.  The total number of neurons 
(Peripherin/NF200-positive) and the number of GFRα3-positive, TRPV1-positive or both 
TRPV1 and GFRα3-positive neurons was determined in at least three 40x fields from a 
minimum of four nonadjacent sections.  Only neurons with a visible nucleus were counted 
because the neurons from ART-OE mice are hypertrophied and therefore would be 
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overrepresented if neuronal profiles were counted.  A minimum of 1000 neurons/animal were 
counted in 3 WT and 3 ART-OE mice.   Soma size was also measured using NIH Image J 
software.  A minimum of 150 profiles with nuclei were measured for each animal.       
2.5 SURGICAL PROCEDURE FOR RETROGRADE LABELING OF LINGUAL 
AFFERENTS 
Animals were lightly anesthetized with inhaled isoflurane and then deeply anesthetized 
with an intraperitoneal injection of 2.5% avertin (2,2,2-tribromoethanol tert-amyl alcohol diluted 
in 0.9% saline; 20 μl/g body weight).  The tongue was extracted slightly from the mouth and 
approximately 1μl of 2% wheat germ agglutin (WGA-488) in sterile saline was injected into the 
superficial dorsal epithelium of the tip of the tongue using a glass micropipette.  Injections were 
performed bilaterally.  The injection sites were carefully washed with saline and dried with a 
cotton swab to prevent leakage to surrounding tissues.  Mice were allowed to recover for two 
days and then processed for immunocytochemistry.   
2.6 TISSUE PREPARATION 
Animals were anesthetized as described above and then transcardially perfused with ice 
cold 4% paraformaldehyde in 0.1M phosphate buffer (PB), pH 7.4.  Trigeminal ganglia and 
tongues were collected by dissection.  Trigeminal ganglia were embedded in 10% gelatin, post-
fixed for 1hr in 4% paraformaldehyde and then cryoprotected in 25% sucrose at 4°C overnight.  
35μm sections were cut using a sliding microtome.  The tongues were cryoprotected in 25% 
sucrose overnight and then 20μM sections cut on a cryostat.  Immunocytochemistry was 
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performed for TRPV1, GFRα3, CGRP and IB4 using the primary and secondary antibody 
concentrations and methods described in the Tissue Immunolabeling section above. 
2.7 CONFOCAL ANALYSIS OF WGA-BACKLABELED IMMUNOPOSITIVE 
TRIGEMINAL NEURONS  
Retrogradely-labeled afferents were visualized using a Leica confocal microscope (Leica 
Microsystems; Wetzlar, Germany).    WGA-positive neurons were counted at 40X in at least 4 
non-overlapping fields from 4 sections (spaced at least 175μM apart).  A minimum of 3 WT and 
3 ART-OE mice were analyzed.  Since some cell bodies in ART-OE mice are hypertrophied, we 
only analyzed cells with a visible nucleus to minimize bias from this hypertrophy.  The number 
of WGA-positive neurons that were also TRPV1-positive, IB4-positive, CGRP-positive or 
GFRα3-positive was determined. 
2.8 LINGUAL NERVE ANALYSIS 
Lingual nerve segments were removed, post-fixed 2 hr in 4% paraformaldehyde and 2% 
glutaraldehyde, washed in 0.1 M phosphate buffer, immersed in osmium tetraoxide for 90 min at 
4°C, dehydrated in graded ethanols, embedded in Spurr’s resin (EM Corporation), and cut at 
0.7–0.8 nm on an ultramicrotome (Reichert Ultracut E). Sections were stained with lead citrate 
and uranyl acetate and photographed on an electron microscope.  The number of myelinated and 
unmyelinated axons was determined for three images (2900x) from three WT and three ART-OE 
mice.  To determine axon diameters, axon profiles were measured in each group using NIH 
Image J software.  
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2.9 REAL TIME PCR ANALYSIS OF NOCICEPTOR-RELATED GENES 
RNA was isolated from TG and DRG using Trizol purification (Invitrogen).  RNA was 
DNased to remove genomic DNA and 1 μg reverse transcribed using Superscript (Invitrogen).  
SYBR Green PCR amplification was performed using an Applied Biosystems 5700 real-time 
thermal cycler.  The thermal cycler measures the relative fluorescence of SYBR Green bound to 
double-stranded DNA compared to a passive reference for each cycle.  Threshold cycle (Ct) 
values, the cycle number in which SYBR Green fluorescence rises above background, were 
recorded as a measure of initial template concentration.  Relative fold changes in RNA levels 
were calculated by the ddCt method (Livak and Schmittgen, 2001) using GADPH as a reference 
standard.  Primers for GAPDH, TRPV1, TRPV2, TRPV3, TRPV4, TRPM8, TRPA1, GFRα3, 
RET, and TrkA were designed using ABI software (Table 1).  Statistical significance was 
determined using a Student’s t-test. 
2.10 HARGREAVES’ TEST (HEAT) 
Transgenic mice of mixed gender were tested for heat sensitivity using the Hargreaves’ 
test (Hargreaves et al., 1988). Mice were placed on a 30°C heated glass surface in individual 
chambers (10.0 cm in length x 10.0 cm in width x 13.0cm in height) of a 16-chamber plexiglass 
container (IITC Inc., Woodland Hills, CA). Animals were acclimated to the apparatus for 1.5 h 
prior to testing. The apparatus was set at a laser intensity of 15% and testing done using repeated 
measures (2 measures per foot) of the left and right glabrous hindpaw skin.  Four response times 
were averaged for each animal. Mean response times for each set of animals were determined 
and values expressed ± the standard error of the mean (SEM). Significance was determined using 
Student’s t test. 
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Table 1.  Primer Sequences used for real time PCR assays. 
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2.11 COLD TAIL WITHDRAWAL ASSAY 
For cold measures, individual mice (10 WT, 10 ART-OE) were restrained in an open-
ended tube and the distal third of the tail immersed in an ethanol bath (Mogil and Adhikari, 
1999).  Assays were done at 0°C and -15°C on two different sets of mice.  Temperature of the 
bath was maintained using a temperature controlled ethanol bath (NesLab RTE7).  The time until 
a vigorous tail withdrawal response occurred was measured to 0.1 sec using a stopwatch. 
2.12 NOXIOUS COLD ASSAY 
Mice were placed on a block of ice covered by a plexiglass box (2˝ wide x 2˝ long x 12˝ 
high) and responses tested for 1 minute.  The block of ice was kept frozen in a -20°C freezer and 
was removed from the freezer just prior to testing.  To minimize changes in temperature, a fresh 
block of ice was used for every 5 mice.  Since each mouse was tested for only 1 minute, there 
was very little melting of the ice block.  While the exact temperature of the ice block is difficult 
to know for certain, there was no appreciable melting of the ice indicating that temperature was 
less than 0°C.  Given the large number of nocifensive responses (10-20 in 1 minute) observed in 
our study in comparison to others (Kwan et al show less than 10 paw lifts in a 5 minute testing 
period in response to cold plate set at 0°C;(Kwan et al., 2006)), the temperature of the ice block 
was most likely in the range of -20°C to -10°C during our testing.  The latency to first response 
and number of nocifensive events (paw lifts, paw biting, paw shaking, or jumps) were recorded.  
Because we found that cold responses desensitize with repeated testing, each mouse was tested 
only once. 
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2.13 PLACE PREFERENCE ASSAY 
Mice were placed in a 2 inch by 4 inch plexiglass chamber where one side of the floor 
was room temperature (22°C) and the other side was 5°C.  The cold side was connected to a 
temperature regulator (Physitemp BFS-30TC Controller, Physitemp Instruments, Clifton, NJ) 
and cool water was circulated through the cold block to dissipate heat (Physitemp PTU-3 Pump 
and Tank Unit).  Mice were initially placed on the 5°C side.  Mice were tested for 5 minutes and 
time spent on each side was recorded using a stopwatch.  Because we found that cold responses 
desensitize with repeated testing, each mouse was tested only once.   
2.14 DRINKING BEHAVIOR 
Mice were tested for oral sensitivity to capsaicin or mustard oil using a drinking 
paradigm modified from previous studies (Simons et al., 2001; Furuse et al., 2002).  A total of 40 
mice were used for these experiments (10 WT males, 10 WT females, 10 ART-OE males, 10 
ART-OE females).  Mice were housed in cages individually and given food and water ad litum.  
For the drinking aversion test, a two water bottle choice test was used.  One bottle contained 
normal water plus vehicle and the other bottle contained 1μM capsaicin (Sigma-Aldrich) or 
100μM mustard oil (Sigma-Aldrich).  Mice were tested over 72 hrs.  Mice were allowed to drink 
freely from the two bottles for 24hrs and then the volume consumed was measured.  To ensure 
that there was not a place preference, the bottle positions were reversed at the end of each day.  
The average volume consumed over the three test days and the ratio of capsaicin or mustard oil 
intake versus total liquid intake (percentage) was calculated.  To ensure that there was not a 
difference in the total volume of liquid consumed by the transgenic compared to the wildtype 
mice, mice were also tested using the same paradigm with both bottles filled with normal water.  
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All mice drank the same volume of water and did not display a bottle preference when both 
bottles contained normal water.    
2.15 MUSTARD OIL NOCIFENSIVE BEHAVIOR 
To test responses to mustard oil, we used a previously established protocol (Caterina et 
al., 2000).  Briefly, 10% mustard oil (allyl isothiocyanate, Sigma-Aldrich CH-9471) in mineral 
oil was painted onto the plantar surface of one of the mouse hindpaws and then nocifensive 
behavior (licking, biting, foot lifts) was quantified.  Both the number of events and the duration 
of nocifensive behavior were determined.  Mice began to display nocifensive behavior almost 
immediately after mustard oil was painted on the paw.  Duration of behavior was measured as 
the time from application of mustard oil to the time where 30 seconds had elapsed from the last 
nocifensive event.  Mice were tested for a maximum of 5 minutes.  To minimize spread of the 
mustard oil to the non-painted paw, mice were tested on an absorbent pad.  Immediately 
following testing, mice were sacrificed using an overdose of inhaled isoflurance and the 
diameters of the painted and non-painted paws were measured using a caliper micrometer.    
2.16 CAPSAICIN NOCIFENSIVE BEHAVIOR 
Nocifensive behavior and thermal sensitivity to noxious heat were assayed following 
injection of the TRPV1 agonist, capsaicin, into the mouse hindpaw,  These studies utilized a 
previously reported injection paradigm (Caterina et al., 2000).  Briefly, following baseline testing 
for sensitivity to noxious heat using the Hargreave’s test (see above), 10μl capsaicin solution 
(1μg in 10μl saline/10% ethanol/0.5% Tween 20) or 10μl saline with 0.5% Tween 20 was 
injected subcutaneously into the plantar surface of one of the hindpaws.  Nocifensive behavior 
was then determined as described previously in the mustard oil behavior section.  Following 
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testing, mice were tested for thermal sensitivity to noxious heat using the Hargreave’s test at 10 
min, 30 min and 60 min post-injection.  In contrast to the mustard oil studies, capsaicin injection 
did not lead to any appreciable paw edema at 5 min and therefore paw diameter was not 
measured in these studies.   
2.17 COMPLETE FREUND’S ADJUVANT (CFA) INJECTION AND BEHAVIOR 
Detailed methods for this model of inflammatory pain have been previously described 
(Zwick et al., 2002).  Briefly, 10 WT and 10 ART-OE male mice were anesthetized with 
isoflurane and 20μl of complete Freund’s adjuvant (CFA) emulsion was injected into the plantar 
surface of both hindpaws.  Hargreave’s testing was performed 1, 3, 5, and 7 days post-CFA 
injection to evaluate withdrawal latencies to noxious radiant heat.    
2.18 MECHANICAL SENSITIVITY BEHAVIOR 
Mice were tested for mechanical sensitivity using von Frey filaments.  Two groups of 
mice were tested.  The first group contained mixed gender mice (WT: n=10, ART-OE: n=10) 
and were testing on the dorsal surface of the hindpaw using the “up/down” method.  Briefly, von 
Frey filaments were applied 5 times to the dorsal hindpaw and response (lifting. biting, etc) to 
any of the 5 applications recorded as a response.  High and low force filaments were alternated 
until a threshold of sensitivity was reached.  The second group of mice contained only male mice 
(WT: n=10, ART-OE: n=10) and were tested on the plantar surface of the hindpaw.  The number 
of responses to three separate trials of 5 applications of a 4.08 (1g) von Frey filament to each 
hindpaw were determined.  The responses are represented as a percentage of total applications.    
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2.19  CELL PREPARATION FOR CALCIUM IMAGING OF TRIGEMINAL 
NEURONS AND IDENTIFIED LINGUAL AFFERENTS 
Lingual Afferents were backlabeled as described above.  Two days following injection, 
mice were perfused with ice cold Ca+2/Mg+2-free Hanks’ Balanced Salt Solution (HBSS) (Gibco 
14170-112).  Trigeminal ganglia were dissected, placed in ice cold HBSS and minced using 
iridectomy scissors to pieces approximately the size of a DRG.  Trigeminal ganglia were then 
incubated in 60U of papain in a solution of cysteine (1mg/3ml HBSS) and saturated NaHCO3 for 
20 min at 37°C, the solution removed and 12mg collagenase Type II and 14mg dispase Type II 
in 3 ml HBSS added for 20 min at 37°C.   Cells were spun at 500g for 4min and the 
collagenase/dispase solution was removed.  Cells were resuspended in 500μl L-15 (Gibco) plus 
10% FBS (Gibco) and 1M HEPES and triturated.  The resuspended cells were gently placed on 
the top of a 40/60 percoll gradient (Fisher) (4mls 40% percoll in L15 layered on 4mls 60% 
percoll) and spun at 1300g for 10min.  The upper layer containing myelin debris was removed 
and washed with 4ml of fresh L15.  Cells were spun at 1000g for 6min and the resultant pellet of 
cells was resuspended in 400ul F12 media (Gibco) with 10% FBS and antibiotics 
(peniciliin/streptomycin, 50 units/ml).   No additional growth factors were added to the culture 
medium.  Cells were plated onto laminin (0.1mg/mL) and poly-d-lysine (5mg) coated glass 
coverslips. Cells were incubated for 2 h at 37°C, fed with F12 media and incubated overnight.  
Calcium imaging was performed 12-24hrs after plating. 
2.20 IMAGING PROTOCOL 
Cells were loaded with calcium indicator by incubation with HBSS containing bovine 
serum albumin and 2µM of the acetoxymethyl ester of fura-2 (Molecular Probes, Oregon) for 30 
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min at 37°C. Coverslips were mounted on an Olympus upright microscope stage with HBSS 
buffer flowing at 5 ml/minute.  Perfusion rate was controlled with a gravity flow system (Warner 
VC66) and perfusate temperature was maintained at 30oC using a heated stage and an in-line 
heating system (Warner PH1, SHM-6, TC344B).  Drugs were delivered with a rapid-switching 
local perfusion system.  Firmly attached, WGA-backlabeled cells were identified using a 480nm 
filter and chosen as regions of interest in the software (Simple PCI; CImaging).  Unlabeled, 
adjacent cells were also identified and imaged.  All fields were first tested with brief application 
of 50mM K+ (high K+) and Ca++ transients imaged to standardize pipette placement and to insure 
that cells were healthy and responsive.  Responses were measured as the ratio of absorbance at 
340nm to that obtained at 380nm (Sutter DG4; Retiga 1300; ΔF340/380); peak responses were > 
0.08 ΔF340/380 and were easily distinguished from optical noise (< 0.02 ΔF340/380).  Absorbance 
data at 340 and 380 nm were collected at one per second.  Cells not responsive to high K+ 
application were not analyzed further.  Calcium transients were examined in response to local 
application of either 1μM capsaicin (5-6sec) or 100 μM mustard oil (15-20sec) using a rapid-
switching perfusion system (Warner Instruments).   These doses of capsaicin and mustard oil 
were chosen because previous studies in our laboratory indicated that they elicited responses 
>0.1 ΔF340/380 from the maximal number of cells and could be applied repeatedly without 
significant loss in the number of responding cells.  These concentrations are also within the range 
reported in the literature for calcium imaging in mouse trigeminal neurons. 
In the standard protocol, cells were first tested with mustard oil (100μM) allowed to 
return to baseline (typically 5 minutes), tested with application of capsaicin (1μM) and allowed 
to return to baseline (typically 10 minutes), and then tested a second time with mustard oil.  A 
separate group of cells was only tested with capsaicin.  However, there were no differences in 
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capsaicin responses between the cells only exposed to capsaicin and cells exposed first to 
mustard oil and then to capsaicin.  Therefore, in our analysis of capsaicin responsive cells, these 
two sets of cells were pooled.   
The number of capsaicin or mustard oil responsive cells was determined as a percentage 
of total healthy cells (cells that responded to high K+).  Ca++ response peak and area (Fpeak, Farea) 
were calculated using Microsoft Excel for suprathreshold responses (peak response > 0.08 
ΔF340/380) as a measure of total Ca++ influx. The portion of the calcium response used for this 
measurement included the entire curve from the initiation of the response until the point at which 
the calcium signal returned to the prestimulus baseline.  Response parameters were compared for 
significance using Student’s t test.  10mM capsaicin (Sigma-Aldrich) in 1-methyl-2-
pyrrolidinone was used as a stock solution; 1.0 µM capsaicin was made fresh daily in HBSS.  
100mM mustard oil (Sigma-Aldrich) in 1-methyl-2-pyrrolidinone was made fresh daily and 
diluted to 100μM using HBSS.  
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3.0  ANATOMY RESULTS 
3.1 HUMAN K14 KERATIN PROMOTER DRIVES ARTEMIN TRANSGENE 
EXPRESSION IN THE SKIN AND TONGUE 
The human K14 keratin promoter directed expression of artemin in basal keratinocytes of 
the epidermis and keratinized epithelium of the oral cavity (Figure 4A).  K14 transgene 
expression begins at approximately embryonic day E11, continues into adulthood and has 
previously been shown to successfully express high levels of NGF, NT3, BNDF, NT4 and 
GDNF in the skin and oral cavity (Albers et al., 1994; Albers et al., 1996; Krimm et al., 2001; 
Zwick et al., 2002).  Artemin transgene expression was confirmed using RT-PCR and an anti-
artemin antibody.  RT-PCR analysis showed a low level of artemin mRNA in skin from wildtype 
(WT) mice and an enhanced level in skin from artemin overexpresser (ART-OE) mice (Figure 
4B).  Immunoreactivity for artemin protein in the epithelium of WT skin and tongue was only 
slightly detectable but was significantly enhanced in the K14 keratin expressing keratinocytes of 
the ART-OE mouse (Figure 4C & 4D).   
3.2 ARTEMIN OVEREXPRESSION INCREASES NEURON NUMBER IN SENSORY 
GANGLIA  
On gross examination, both DRG and TG were enlarged in the ART-OE mice (Figure 
5A), suggesting that artemin could be a neuronal survival factor.  Artemin protein is retrogradely  
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 Figure 4.  K14 keratin promoter drives artemin transgene expression in skin and tongue keratinocytes. 
A)  Diagram of transgene construct used for isolation of artemin overexpresser (ART-OE) mice.  The keratin K14 
promoter drives expression of the artemin sequence represented by black boxes.  Lines connecting the boxes 
indicate two intronic sequences retained in the artemin sequence.  The 3’ hGH sequence provides splice sites and a 
poly A (PA) addition signal. Arrow indicates transcription start site, ATG and TGA are translation start and stop 
sites, respectively. B) RT-PCR analysis of RNA isolated from wildtype (WT, n=3) and transgenic (ART-OE, n=3) 
back skin showing increased expression of artemin mRNA in ART-OE skin. Lanes 1-6 show amplicons obtained 
using primers to the artemin gene sequence; lanes 7-12 show products using transgene specific PCR primers; lanes 
13 and 15 are negative controls for the PCR reaction and lanes 14 and 16 are positive controls for the artemin and 
transgene sequences, respectively. Note significant enhancement in level of artemin mRNA and lack of transgene 
expression in transgenic skin samples.  C) Immunolabeling of whisker pad skin from WT (top panel) and ART-OE 
(bottom) mice using an antibody to artemin. Artemin protein is significantly increased in basal keratinocytes of 
ART-OE mice. Bar in lower panel, 25Mm.  D) Immunolabeling for artemin in tongue epithelium shows increased 
artemin expression in the keratinized epithelium of the ART-OE tongue (bottom panel) compared to WT tongue 
(upper panel). 
 37 
transported from the skin and tongue to DRG and TG neurons as indicated by increased artemin 
immunoreactivity in the ART-OE ganglia (Figure 5B).  Increased artemin protein produced a 
modest increase (20.5%) in cell number in the ART-OE mouse (DRG: WT 4800±238; ART-OE 
5788±250; p<0.011) (Figure 5C).  These results support a role for artemin as a developmental 
survival factor for a subpopulation of sensory neurons.  
3.3 ARTEMIN OVEREXPRESSION MODULATES GFRΑ3 EXPRESSION 
Sensory ganglia were labeled with an anti-GFRα3 antibody to determine if properties of 
GFRα3-positive neurons changed in response to the increase in skin-derived artemin.   The 
percent of GFRα3-positive neurons was unchanged in ART-OE DRG (WT 19.64 ± 0.57 %; 
ART-OE 18.07 ± 1.47 %), but cell diameter measures showed these neurons to be hypertrophied 
(WT 20.03 ±0.67 μm; ART-OE 26.09 ± 0.99 μm; p<0.05) (Fig. 6A, D). GFRα3 expression was 
also examined on the transcriptional level by assaying the relative abundance of GFRα3 mRNA 
in WT and ART-OE ganglia (Table 2). Real time PCR analysis of lumbar DRG and TG showed 
GFRα3 mRNA increased by 34% and 81% in the DRG and TG, respectively, of ART-OE 
animals (p≤0.005). Since the percent of GFRα3-positive neurons was unchanged, this increase in 
GFRα3 mRNA suggests its expression was elevated on a per cell level. Interestingly, transcripts 
encoding tyrosine kinases Ret and TrkA, which are coexpressed in ~80% of GFRα3-positive 
neurons (Orozco et al., 2001), were differentially regulated in ART-OE ganglia (Table 2). 
Relative to WT ganglia, Ret transcript level was unchanged whereas TrkA mRNA levels were 
increased 37% and 56% in DRG and TG, respectively (p<0.005). 
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Figure 5.  Artemin overexpression in the skin increases sensory ganglia size and neuronal number. 
A)  Ganglia from ART-OE mice are larger relative to WT ganglia. DRG showed a similar enlargement (not shown). 
B) Artemin is retrogradely transported from the skin as indicated by artemin-immunoreactivity in trigeminal ganglia 
neurons of ART-OE (arrows) but not WT mice. C)  Total cell counts showed that there was a modest increase in cell 
number (20.5%) in the L4 DRG from ART-OE mice.  WT; n=3; ART-OE; n=4. Mean ± SEM, P<0.05 vs. WT.   
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 Figure 6.  Sensory neurons responsive to artemin are hypertrophied and express TRPV1. 
A) GFRα3 immunolabeling (green) of WT (A, C) and ART-OE (D, F) DRG show GFRα3-positive neurons are 
larger in size. Nearly all GFRα3 neurons in WT (B) and ART-OE (E) ganglia express TRPV1 (red; arrows) though 
several TRPV1-labeled neurons do not express GFRα3 (arrowheads; see merged images of WT (C) and ART-OE 
(F) ganglia). Trigeminal neurons showed a similar hypertrophy in TRPV1/GFRα3 neuron size. Bar in C = 60 µm 
and applies to all panels. 
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Table 2.  Change in expression of receptor and TRP channel genes in lumbar DRG (L3, L4 and L5) and TG 
of WT and ART-OE mice. 
RT-PCR assays using RNA from DRG and TG were performed using 4-6 animals per group.  **P<0.0005, 
*P<0.005. 
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3.4 ARTEMIN INCREASES TRPV1 MRNA IN SENSORY GANGLIA 
Since all GFRα3-positive afferents in mouse are also TRPV1-positive (Orozco et al., 
2001), we tested whether transcriptional regulation of TRPV1 or other TRP channel genes was 
altered in ART-OE ganglia using SYBR RT-PCR (Table 2).  TRPV1 transcript level was 61% 
and 190% higher in the DRG and TG of the ART-OE mice compared to WT mice.  No change in 
TRPV2, TRPV3, or TRPV4 was observed.   
3.5 ARTEMIN CAUSES HYPERTROPHY OF TRPV1-POSITIVE AFFERENTS 
Immunolabeling of L4/L5 DRG with antibodies to TRPV1 and GFRα3 (Figure 6B, 6E) 
showed most GFRα3-positive neurons expressed TRPV1 in both WT (94.25 ± 0.88%) and ART-
OE (96.55 ± 2.00) mice, although not all TRPV1 neurons were GFRα3-positive (in either WT or 
ART-OE). The overall percentage of TRPV1 neurons in ART-OE mice was also unchanged 
compared to WT mice (WT 27.53 ± 1.19 %; ART-OE 28.81 ± 2.75 %). However, TRPV1 
neurons in ART-OE ganglia showed hypertrophy in size (WT 20.42 ± 3.90 µM; ART-OE 24.43 
± 1.39 µM; p<0.05) (Fig. 6B, E).  Increases in somal size of GFRα3/TRPV1-positive neurons 
were even larger in the TG of ART-OE mice compared to the differences observed between the 
WT and ART-OE DRG (see Figure 10 compared to Figure 6).  These results in DRG and TG 
confirm that the GFRα3/TRPV1 neuron population was responsive to artemin.   
The increased diameter of TRPV1-positive neurons raised the possibility that increased 
levels of artemin alter peripheral projection patterns of GFRα3-,TRPV1-positive neurons. Skin 
and tongue innervation were therefore examined by immunolabeling whisker pad, backskin, 
footpad skin and tongue epithelium. Using the general neuronal marker PGP-9.5, no major 
change in innervation density or projection pattern was found in the skin (not shown). Colabeling 
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of WT and ART-OE whisker pad and footpad skin using anti-GFRα3 and anti-TRPV1 antibodies 
did, however, reveal a significant change in afferent innervation in ART-OE skin. Whisker pad 
(Figure 7, 8) and footpad skin (not shown) of ART-OE mice showed greater density of GFRα3-
labeled afferents compared to WT skin (compare Figure 7A and 7D; Fig. 8A and 8D). In 
addition, the number of TRPV1-positive afferents in ART-OE skin was significantly increased in 
dermal and epidermal compartments (compare Fig. 7B, 7E; Fig. 8B, 8E).  In addition, the tongue 
epithelium showed increased PGP9.5 staining (Figure 9A) and increased GFRα3-positive (and 
presumptive TRPV1-positive) fibers (Figure 9B).  Thus, increased artemin in skin and tongue 
enhances projections of TRPV1- and GFRα3-positive fibers.  Whether this is due to an increase 
in the number of TRPV1/GFRα3-positive afferents or increased branching of processes is 
unclear. However, the somal hypertrophy of these neurons and increase in TRPV1 and GFRα3 
mRNA expression is consistent with the presence and maintenance of more highly branched 
peripheral processes.  
3.6 THE TRPA1 CHANNEL PROTEIN IS A MARKER FOR GFRΑ3 NEURONS 
AND IS MODULATED BY ARTEMIN LEVEL 
In addition to TRPV1, increased skin expression of artemin led to enhanced expression of 
TRPA1, a channel protein reported to be activated by pungent compounds and noxious cold 
(Peier et al., 2002; Bandell et al., 2004; Bautista et al., 2005). TRPA1 mRNA was increased 
210% in DRG and 403% in TG of ART-OE transgenic mice compared to WT (Table 2).  In WT 
(Fig. 10A-10C) and ART-OE (Figure 10D-10F) TG and DRG (not shown) immunolabeled with 
antibodies to TRPA1 and GFRα3, a large degree of overlap in TRPA1 and GFRα3 expression 
occurred.  Based on this overlap it appears that TRPA1 is expressed by nearly all sensory 
neurons that are GFRα3-positive and therefore artemin-responsive and TRPV1-positive. In  
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Figure 7.  Skin-derived artemin increases cutaneous GFRα3-positive afferents and intensity of TRPV1 
labeling.  
Low power view compares innervation of whisker pad skin of WT (A-C) and ART-OE (D-F) animals. An increase 
in GFRα3-positive afferents (green, arrows) occurs in dermis of ART-OE skin. Immunolabeling with anti-TRPV1 
(red, B, E) shows high expression in ART-OE afferents (E). Few TRPV1 fibers were seen in WT skin (B). TRPV1 
labeling of GFRα3 afferents of ART-OE skin was particularly evident in merged images (F) where overlap appears 
yellow. Overlap was rarely seen in WT skin (C). Asterisks (panels D, E and F) indicate appearance of GFRα3 and 
TRPV1 afferents in epidermis of ART-OE skin (see Fig. 8). Arrowheads in D-F indicate a GFRα3-positive fiber that 
is not TRPV1 positive and may represent sympathetic innervation. Bar in F = 100 µm and applies to all panels. Epi, 
epidermis; sb, sebaceous gland; hf, hair follicle. 
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Figure 8.  Artemin increases the intensity of TRPV1 expression in GFRα3 epidermal afferents.  
High magnification view of GFRα3 (green, A,D) and TRPV1 (red, B,E) labeling in whisker pad epidermis of adult 
WT (A,B and C) and ART-OE (D,E and F) mice. In WT skin, few dermal (arrows) and epidermal (arrowheads) 
GFRα3-positive fibers express TRPV1. In contrast, ART-OE skin has many TRPV1-positive fibers that appear to 
sprout in the epidermal layer (panels E, F). Bar in E = 40 µm and applies to all panels. Epi, epidermis; hf, hair 
follicle. 
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Figure 9. Tongue epithelium from ART-OE mice are hyperinnervated and have increased GFRα3-positive 
fibers. 
A & B) High magnification view (40X) of immunolabeling for the general neuronal marker PGP9.5.  Tongue 
epithelium from ART-OE mice (B) is hyperinnervated by PGP9.5-positive fibers (arrows) compared to WT (A).  C 
& D) Low magnification view (20X) of GFRα3 immunolabeling in tongue.  Tongue epithelium showed increased 
GFRα3 staining in ART-OE (D) compared to WT (C) mice. 
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Figure 10.  GFRα3-positive afferents express the TRPA1 channel. 
GFRα3 immunolabeling (green) of WT (A, B, C) and ART-OE (D, E, F) trigeminal ganglia show GFRα3-labeled 
neurons exhibit TRPA1 immunoreactivity (red). Complete overlap in labeling occurred in both WT and ART-OE 
ganglia.  Similar overlap in GFRα3 and TRPA1 labeling was found in the DRG. Bar in F = 70 µm and applies to all 
panels. 
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addition, TRPA1 immunolabeling of neurons in transgenic ganglia appeared more intense, likely 
reflecting the increase in TRPA1 mRNA shown by RT-PCR assay (Table 2). TRPM8, a TRP 
channel proposed to detect innocuous cooling (McKemy et al., 2002; Peier et al., 2002), was also 
assayed and found to be reduced in the TG (-70%) of ART-OE mice (p≤0.005). 
3.7 TONGUES OF ART-OE MICE ARE HYPERINNERVATED BY GFRΑ3, TRPV1 
AND PRESUMPTIVE TRPA1-POSITIVE LINGUAL AFFERENTS. 
Since the heavily keratinized tongue is a site that routinely contacts the proposed ligands 
for TRPV1 (capsaicin, heat, low pH) and TRPA1 (mustard oil, noxious cold), we hypothesized 
that at least a portion of the changes in TRPV1 and TRPA1 gene expression might occur in 
afferents innervating the tongue.  To test this and to characterize the normal anatomy and 
neurochemistry of lingual afferents, we retrogradely-labeled the trigeminal neurons that 
innervate the tongue using WGA and then performed immunohistochemistry for GFRα3, 
TRPV1, IB4, and CGRP (Figure 11A).  Our results show that approximately 25% of lingual 
afferents in WT mice contain TRPV1 (Figure 11B), similar to the percentage in cutaneous 
afferents (Christianson et al., 2006).  However, in contrast to cutaneous afferents, where the 
majority of afferents are IB4-positive, very few (10%) lingual afferents bind IB4 and many 
(50%) contain CGRP (Figure 11B).  Nearly 25% of lingual afferents express GFRα3 (Figure 
11B) and nearly all contain CGRP (GFRα3/CGRP overlap; WT 96.15 ± 3.85%).  These data 
suggest that lingual afferents may have properties somewhat different from cutaneous afferents. 
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Figure 11.  WGA-Positive Lingual Afferents from ART-OE mice have increased GFRα3, TRPV1 and IB4. 
Upper Panel) Immunocytochemistry for TRPV1 (red), IB4 (blue) and TRPV1/IB4 overlap (white, merge) in WT 
and ART-OE mice.  Note the increase in number of neurons expressing TRPV1 and IB4 in the ART-OE (arrows, 
merged panel, white) compared to the WT.  Also note the somal hypertrophy in the ART-OE.  Lower Panel) 
Quantification of the percentage of WGA-positive lingual afferents that also express GFRα3 and other 
neurochemical markers (TRPV1, IB4, CGRP).  Note that in ART-OE mice (red bars) there is an increased 
percentage of WGA-positive neurons that also express GFRα3, TRPV1, IB4, or both TRPV1 and IB4 compared to 
WT mice (blue bars).  However, there was no change in number of WGA-positive neurons that express CGRP in the 
ART-OE.  Mean Percentage ± SEM.  Analysis represents at least 4 WT and 4 ART-OE mice for all neurochemical 
markers, except CGRP where 3 animals from each genotype were quantified.  P<0.05 vs. WT.   
 
 49 
In the ART-OE mice, there was an increased number of WGA-positive afferents that 
were also GFRα3-positive (WT 27.40 ± 1.92 %; ART-OE 40.32 ± 2.77 %; p≤0.005), TRPV1-
positive (WT 25.55 ± 1.42 %; ART-OE 41.49 ± 2.14 %; p≤0.005), IB4-positive  (WT 11.16 ± 
1.70 %; ART-OE 29.69 ± 1.13 %; p≤0.005), or both TRPV1 and IB4-positive (WT 7.70 ± 1.70 
%; ART-OE 28.12 ± 1.05 %; p≤0.005) (Figure 11B).  There was no change in the number of 
CGRP-positive (WT 49.48 ± 4.84 %; ART-OE 54.28 ± 0.59 %; p=0.21) or CGRP and GFRα3-
positive afferents (WT 96.15 ± 3.85 %; ART-OE 97.74 ± 0.37 %; p=0.36) in the ART-OE mice 
compared to WT mice (Figure 11B).  Since most GFRα3-positive afferents are also TRPA1-
positive (Figure 10, above), these results support the hypothesis that the tongue epithelium of 
ART-OE mice is hyperinnervated by GFRα3, TRPV1 and presumptive TRPA1-positive lingual 
nerve fibers.   
3.8 LINGUAL NERVES FROM ART-OE MICE ARE HYPERTROPHIED  
To examine the fiber diameter and myelination state in lingual afferents, electron 
microscopy was performed.  Low power electron microscopy photomicrographs showed that 
lingual nerves from ART-OE mice were enlarged (Figure 12A).  Lingual nerves from both WT 
and ART-OE mice contained mostly myelinated fibers and there was not a significant difference 
in the percentage of myelinated (WT: 70%; ART-OE; 70%) or unmyelinated fibers in WT or 
ART-OE mice (Figure 12B).  However, in the ART-OE mice, both myelinated and unmyelinated 
fibers were hypertrophied (Figure 12C). 
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Figure 12.  Lingual Nerves from ART-OE mice are hypertrophied. 
A) Low magnification electron microscopy images of lingual nerve cross sections from WT (left) and ART-OE 
(right) mice.  Note the overall enlargement in lingual nerve diameter in the ART-OE mouse.  B)  Quantification of 
the percentage of myelinated and unmyelinated axons in the lingual nerve of WT (blue) and ART-OE (red) mice.  
The majority of axons in both genotypes are myelinated and there was no difference in the percentage of myelinated 
or unmyelinated fibers in WT (n=3) compared to ART-OE mice (n=3).  C) Distribution of myelinated axons by size 
(microns) in WT and ART-OE mice.  There was a small amount of hypertrophy in myelinated axons from ART-OE 
mice (note rightward shift of distribution).  D) Size distribution of unmyelinated axons in WT and ART-OE mice.  
There was a substantial rightward shift in the distribution, indicating that unmyelinated axons from the ART-OE 
were particularly hypertrophied. 
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4.0  BEHAVIOR RESULTS 
To determine the functional significance of the anatomical, neurochemical and gene 
expression changes in the ART-OE mice, we performed a battery of behavioral experiments on 
WT and ART-OE mice.  Because of the increased TRPV1 and TRPA1 expression in the DRG, 
we assessed cutaneous sensitivity to noxious heat using a radiant heat source (Hargreave’s) and 
sensitivity to noxious cold using a cold tail flick assay, a cold ice-block test and a place 
preference test (where one side was cold).  Mechanical sensitivity was also evaluated using von 
Frey filaments.  Since both capsaicin and mustard oil elicit sensations of burning when applied or 
injected into the skin, we tested nocifensive responses to these chemicals and tested oral aversion 
to these ligands using a two-bottle drinking choice test.  In addition, we tested thermal sensitivity 
to heat following capsaicin injection.  Finally, to test responses to general inflammation, CFA 
was injected into the hindpaw of WT and ART-OE mice and thermal sensitivity to heat 
determined 1, 3, 5, and 7 days post-injection.    
4.1 ART-OE MICE ARE HYPERSENSITIVE TO NOXIOUS HEAT 
Mixed gender mice were tested for sensitivity to noxious heat using the Hargreave’s test 
(Figure 13).  ART-OE mice displayed shorter paw withdrawal latencies to radiant heat applied to 
the plantar surface of the hindpaw compared to WT mice (WT 8.05 ± 0.46 s; ART-OE 6.33 ± 
0.27 s; p≤0.005)(Figure 13A).  A separate group of mice divided by gender were also tested prior  
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Figure 13.  ART-OE mice are hypersensitive to noxious heat. 
A)  Animals were acclimated to the Hargreave’s testing apparatus and a focused radiant heat source was applied to 
the glabrous skin of the hindpaw.  Repeated measures of 8 WT (blue) and 8 ART-OE (red) mice showed faster 
withdrawal in ART-OE mice.  B)  In a separate study of 10 WT and 10 ART-OE mice of both genders (40 mice 
total) for baseline measurement prior to capsaicin injection (see Figure 19, day zero), hypersensitivity to noxious 
heat was also seen in male and female ART-OE mice compared to WT mice of the same gender.  There were no 
differences in withdrawal threshold to heat between male mice and female mice of either genotype.  Mean ± SEM. 
*P<0.005 vs WT. 
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to capsaicin injection (see baseline, Figure 20).  A similar hypersensitivity to noxious heat was 
observed in the ART-OE mice in these experiments (Males: WT 12.21 ± 0.56 s; ART-OE 8.25 ± 
0.58 s; p≤0.0005; Females: WT 12.14 ± 1.1 s; ART-OE 8.59 ± 0.36 s; p≤0.005) (Figure 13B).  
These data support an intrinsic role for artemin in regulating sensitivity to noxious heat. 
4.2 ART-OE MICE ARE HYPERSENSITIVE TO NOXIOUS COLD STIMULI 
Because of the robust increases in transcript levels of TRPA1 and the overlap of GFRα3 
expression with TRPA1 (see Figure 10), we tested sensitivity of WT and ART-OE mice to 
noxious cold stimuli.  Two sets of mixed gender mice were tested for sensitivity to noxious cold 
by placing their tails in an ethanol bath set to either -15°C or 0°C and measuring latency to tail 
flick.  Testing showed that ART-OE mice had significantly shorter response times compared to 
WT mice at both -15°C (WT 15.1 ± 2.8 s; ART-OE 5.2 ± 1.0 s; p≤0.005; n=20) and 0°C (WT 
10.7 ± 1.7 s; ART-OE 5.2 ± 1.4 s; p≤0.05; n=40) (Figure 14A & 14B). 
Sensitivity to noxious cold was also tested by placing mice on a block of ice and 
measuring the latency to the first nocifensive event and the number of nocifensive events 
displayed in 1 minute.  In these studies mice were separated by gender.  This test of noxious cold 
applied to the plantar surface of the hindpaw also showed that ART-OE mice were 
hypersensitive to cold (Figure 15).   Both male and female ART-OE had shorter latencies to first 
nocifensive behavior (Males: WT 28.20 ± 2.95; ART-OE 16.00 ± 1.25; p≤0.005; Females: WT 
20.30 ± 1.47; ART-OE 12.30 ± 1.09; p≤0.0005) (Figure 15A).  In addition, both male and female 
ART-OE mice displayed more nocifensive events than WT mice (Males: WT 7 ± 1; ART-OE 13 
± 2; p≤0.005; Females: WT 9 ± 1; ART-OE 17 ± 1; p≤0.0005) (Figure 15B).  Furthermore, the 
female WT and ART-OE mice displayed shorter latencies to first response compared to WT 
male and ART-OE male mice, respectively (p≤0.05).  The female ART-OE mice also showed a  
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Figure 14.  ART-OE mice display hypersensitivity to cold in tail flick assays.  
Response to cold was tested by tail immersion in an ethanol bath set to either -15°C (A) or 0°C (B) using two sets of 
10 WT (blue) and 10 ART-OE (red) mice of mixed gender (40 mice total). Tail flick response was measured to 0.1 s 
with a stopwatch.  ART-OE mice exhibited lower thresholds than WT mice at both -15°C (A) and 0°C (B).  Mean ± 
SEM.  *P<0.05 vs WT. 
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Figure 15.  ART-OE mice display behavioral hypersensitivity to noxious cold (-10°C). 
Ten WT (blue) and 10 ART-OE mice (red) of both genders (40 mice total) were tested for sensitivity to noxious 
cold by placing each mouse on a block of ice covered by a plexiglass box for 1 min. A) Latency to first nocifensive 
response (jumping, paw lifting, paw biting) was recorded to the nearest second using a stopwatch. Both male (left) 
and female (right) ART-OE mice displayed shorter latencies to first nocifensive response. In addition, female mice 
of both genotypes displayed shorter latencies to first nocifensive response. B) Number of nocifensive events 
measured during the 1 min testing period were increased in both male (right) and female (left) ART-OE mice, 
indicating that the ART-OE mice have increased sensitivity to the detection of noxious cold applied to the plantar 
hindpaw skin. In addition, female ART-OE mice displayed increased number of events compared to female WT 
mice. All values mean ± SEM, *P<0.005 vs WT, #P<0.0005 vs females of same genotype. 
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greater number of nocifensive responses compared to female WT mice (p≤0.05).  These results 
indicate that ART-OE mice display increased sensitivity to noxious cold applied to the hindpaw 
and that female mice are somewhat more sensitive to noxious cold than male mice in either 
genotype. 
Finally, cold responses were evaluated using a place preference test where mice were 
given a choice between a surface area at room temperature and another surface at 5°C.  This test 
is considerably different than the ice block and tail withdrawal tests as it requires exploration and 
a conscious decision to avoid the cold side.  Both WT and ART-OE mice preferred the room 
temperature side.  However, ART-OE mice of both genders spent even less time on the cold side 
than WT mice (Males: WT 18.13 ± 1.80 %; ART-OE 10.00 ± 1.58 %; p≤0.005; Females: WT 
25.63 ± 3.56 %; ART-OE 14.07 ± 1.52 %; p≤0.005) (Figure 16).  In addition, in this test both 
WT and ART-OE male mice spent less time on the cold side than females of the same genotype 
(Males: p≤0.05; Females: p≤0.05).  Therefore, in this test male mice of both genotypes are more 
sensitive to choosing between a room temperature area and an area that is noxiously cold.    
Taken together, these three cold behavioral tests indicate that ART-OE mice are 
hypersensitive to cold and, depending on the type of cold assay, cold responses vary with gender. 
4.3 ART-OE MICE ARE NOT SENSITIZED TO MECHANICAL STIMULI 
Mixed gender mice were tested for mechanical sensitivity using Von Frey filaments 
applied to the dorsal surface of the hindpaw.  There was no difference in the mechanical 
thresholds between the WT and ART-OE mice (WT 5.27 ± 0.33 mN; ART-OE 5.14 ± 0.37 mN).  
In male mice tested for the number of responses to a 4.08 mN von Frey filament on the plantar 
surface of the hindpaw, there was also no change in mechanical sensitivity (WT 45 ± 6%; ART-
OE 45 ± 7 %; n=10).    
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Figure 16.  ART-OE mice are hypersensitive to noxious cold (4°C).  
Ten WT (blue) and 10 ART-OE mice (red) of both genders (40 mice total) were tested for sensitivity to noxious 
cold using a place preference test.  Mice were permitted to choose between a region where the floor was room 
temperature (22°C) and another region where the floor was noxiously cold (4°C).  Both male (left) and female 
(right) ART-OE mice spent less time on the cold side than WT mice.  In addition, both WT and ART-OE male mice 
spent less time on the cold side than females of the same genotype.  All values mean ± SEM, *P<0.005 vs WT, 
#P<0.05 vs females of same genotype. 
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4.4 ART-OE MICE ARE HYPERSENSITIVE TO MUSTARD OIL APPLIED TO 
THE HINDPAW 
Since mustard oil is a ligand for TRPA1, we assayed cutaneous sensitivity to topical 
application of mustard oil.  Following application of mustard oil to the plantar surface of the 
hindpaw, both male and female ART-OE mice displayed more nocifensive events than WT mice 
(Males: ART-OE 59 ± 6; WT 20 ± 2; p≤0.000005; Females: ART-OE 36 ± 4; WT 18 ± 3; 
p≤0.005) (Figure 17A).  In addition, the duration of nocifensive behavior was increased in the 
ART-OE mice compared to WT mice (Males: ART-OE 270 ± 26 s; WT 97 ± 3 s; p≤0.000005; 
Females: ART-OE 147 ± 12 s; WT 78 ± 7 s; p≤0.0005) (figure 17B).  Paw edema (calculated as 
percentage edema relative to the unpainted paw) was increased in both male and female ART-
OE mice compared to WT mice (Males: ART-OE 38 ± 3 %; WT 11 ± 2 %; p≤0.000005; 
Females: ART-OE 18 ± 2 %; WT 2 ± 1 %; p≤0.00005) (Figure 17C).  In addition, the duration of 
nocifensive behavior was increased in male WT and male ART-OE mice compared to females of 
the same genotype (Males: p≤0.05; Females: p≤0.0005), suggesting that male mice are 
particularly sensitive (or female mice insensitive) to mustard oil application.  This gender 
difference was also reflected in the percentage of edema which was increased in the male 
compared to female mice in both genotypes (Males: p≤0.005; Females: p≤0.0005).   
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Figure 17.  ART-OE mice are hypersensitive to mustard oil.   
Ten WT (blue) and 10 ART-OE mice (red) of both genders (40 mice total) were tested for behavioral sensitivity to 
topical application of 10% mustard oil to the hindpaw.  The duration of nocifensive behavior and the number of 
nocifensive responses in the five minute testing period were recorded.  In addition, paw edema was measured at the 
end of the study in the painted and unpainted paw and percent edema calculated as the ratio of the painted 
paw/unpainted paw.  Both male (left) and female (right) ART-OE mice displayed increased duration of nocifensive 
behavior (A), increased number of nocifensive responses (B) and increased edema (C) compared to WT mice.  In 
addition male mice of both genotypes displayed increased nocifensive behavior (A) and had increased edema (C) 
compared to female mice of the same genotype, suggesting that male mice are particularly sensitive to mustard oil 
application.  All values mean ± SEM, *P<0.005 vs WT, #P<0.05 vs females of same genotype. 
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4.5 ART-OE MICE ARE HYPERSENSITIVE TO CAPSAICIN INJECTED INTO 
THE HINDPAW 
Nocifensive behavior and thermal sensitivity to noxious heat were assayed following 
injection of the TRPV1 agonist, capsaicin, into the mouse hindpaw.  ART-OE mice of both 
genders display increased duration of nocifensive behavior (Males: WT 98 ± 20; ART-OE 218 ± 
25; p≤0.005; Females: WT 98 ± 28; ART-OE 254 ± 19; p≤0.0005) (Figure 18A) and the number 
of nocifensive responses (Males: WT 23 ± 7; ART-OE 60 ± 10; p≤0.005; Females: WT 20 ± 7, 
ART-OE 61 ± 9; p≤0.005) (Figure 18B).  There were no differences between genders of the 
same genotype.     
Mice were also tested for sensitivity to heat following capsaicin injection because TRPV1 
also responds to heat, particularly during inflammatory conditions.  Compared to baseline 
thermal sensitivity to noxious heat, both WT and ART-OE became sensitized following 
capsaicin injection (P≤0.05)   However, both male and female ART-OE mice had decreased 
withdrawal latencies compared to WT mice of the same gender at 10 min (Males: WT 4.94 ± 
0.97; ART-OE 2.96 ± 0.39; p≤0.05; Females: WT 4.83 ± 0.83; ART-OE 2.82 ± 0.48; p≤0.05), at 
30min (Males: WT 7.91 ± 0.99; ART-OE 4.98 ± 0.85; p≤0.05; Females: WT 4.22 ± 0.65; ART-
OE 6.14 ± 0.83; p≤0.05) and at 60 min post capsaicin injection (Males: WT 14.91 ± 1.99; ART-
OE 6.61 ± 0.63; p≤0.0005; Females: WT 10.47 ± 0.24; ART-OE 6.69 ± 0.64; p≤0.0005) (Figure 
19).  These results suggest that the ART-OE mice were still able to become sensitized to heat 
despite starting at a sensitized baseline relative to WT mice.  Also, note that the slope of the 
curves is similar for WT and ART-OE male mice except that the ART-OE recovered more 
slowly than the WT mice (Figure 19A).  The ART-OE females also displayed this slower 
recovery and became transiently hypoalgesic relative to WT mice at 30 min (Figure 19B).    
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 Figure 18.  ART-OE mice are hypersensitive to capsaicin injected into the hindpaw.   
Ten WT (blue) and 10 ART-OE mice (red) of both genders (40 mice total) were tested for behavioral sensitivity to 
capsaicin injected into the hindpaw.  The duration of nocifensive behavior and the number of nocifensive responses 
in the five minute testing period were recorded.  Both male (left) and female (right) ART-OE mice displayed 
increased duration of nocifensive behavior (A) and increased number of nocifensive responses (B) compared to WT 
mice. All values mean ± SEM, *P<0.005 vs WT. 
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 Figure 19.  ART-OE mice display sensitivity to heat following capsaicin injection.   
Ten WT (blue) and 10 ART-OE mice (red) of both genders (40 mice total) were tested for behavioral sensitivity to 
capsaicin injected into the hindpaw.  Withdrawal response threshold to noxious radiant heat were determined 10, 30 
and 60 minutes post-capsaicin injection.  A)  Both WT and ART-OE male mice displayed shorter withdrawal 
latencies to heat at 10 min and 30 min after capsaicin injection.  However, the percent change from baseline was not 
different in ART-OE compared to the WT mice, indicating that responses to heat were sensitized in a similar manner 
in both genotypes.  However, at 60 min WT mice had returned to baseline whereas ART-OE were still sensitized 
indicating that they recover from capsaicin injection more slowly.  B)  Similar to A), female mice of both genotypes 
became sensitized to heat following capsaicin injection, but the magnitude of the sensitization from baseline was not 
different in ART-OE mice compared to WT mice.  The female ART-OE mice recovered more slowly than the WT 
mice, and also became transiently hypoalgesic relative to WT mice at 30 min.  Mean ± SEM. *P<0.05 vs WT. 
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 There was no change in withdrawal latencies of the uninjected foot relative to baseline in either 
genotype.  In addition, injection of vehicle (10% ethanol, 0.5% Tween 20 in saline) did not 
decrease withdrawal latencies in any of the genotypes at 10, 30, or 60 min post-injection, 
indicating that capsaicin is required for the development of hypersensitivity.  Thus, ART-OE 
mice of both genders display hypersensitivity to noxious heat following capsaicin injection, but 
the pattern of responses is similar to that seen in WT mice (percent change from baseline is not 
different between genotypes). 
4.6 IN A MODEL OF INFLAMMATORY PAIN, ART-OE MICE DISPLAY SIMILAR 
SENSITIVITY TO NOXIOUS HEAT AS WT MICE BUT RECOVER TO THRESHOLDS 
ABOVE BASELINE 
Injection of CFA into the hindpaw is a widely used model of inflammatory pain (Honore 
et al., 2000).   CFA injection causes thermal hyperalgesia with a consistent time course that 
begins within 1 day and lasts for 7-10 days (Fairbanks et al., 2000; Zwick et al., 2003).  Since 
artemin increases robustly in the hindpaw skin following CFA injection (Malin et al 2006) and 
ART-OE mice have increased innervation by GFRα3-positive fibers in the footpad skin, we 
tested for further sensitization to noxious heat following CFA injection.  Both WT and ART-OE 
male mice had decreased withdrawal latency to noxious heat in the Hargreave’s test following 
induction of inflammation with CFA relative to baseline (P≤0.0005).  ART-OE mice also had 
significantly shorter withdrawal latencies at day 3 (WT 8.42 ± 0.93 s; ART-OE 6.57 ± 0.33 s; 
p≤0.05), day 5 (WT 11.21 ± 0.94 s; ART-OE  9.21 ± 0.25 s; p≤0.05) and day 7 (WT 12.04 ± 
1.10 s; ART-OE  9.44 ± 0.56 s; p≤0.05) post-CFA compared to WT mice (Figure 20).  However, 
examined on a percentage change from baseline, there was no difference in the ART-OE mice  
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 Figure 20.  ART-OE mice display similar heat sensitivity to CFA injection 
Ten WT (blue) and 10 ART-OE (red) male mice were tested for behavioral sensitivity to noxious heat following 
CFA induced inflammation.  Both WT and ART-OE mice displayed decreased heat thresholds following CFA 
injection but there was not a difference in the magnitude of the decrease from baseline between the ART-OE and the 
WT mice.  Generally, WT and ART-OE responded with a similar pattern of sensitivity to heat after CFA, although 
ART-OE became hypoalgesic relative to baseline at day 5 and day 7, suggesting that these mice overcompensate in 
their recovery.  Mean ± SEM. *P<0.05 vs WT. 
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compared to WT mice.  This suggests that WT and ART-OE mice display similar responses to 
CFA-induced inflammation and that despite baseline thresholds that are decreased relative to WT 
mice, ART-OE can still become further sensitized to noxious heat.  In addition, when ART-OE 
mice recover from CFA injection, they display decreased sensitivity (hypoalgesia) at day 5 and 
day 7 compared to baseline (p≤0.05), suggesting that they overcompensate for the inflammatory 
insult.  A similar compensatory response was seen in animals overexpressing NGF in the skin 
(Zwick et al., 2003).    
4.7 ART-OE MICE DISPLAY ORAL SENSITIVITY TO CAPSAICIN AND 
MUSTARD OIL IN THEIR DRINKING WATER 
Mice were tested for oral sensitivity to capsaicin or mustard oil using a two bottle 
drinking test.  In this test, one bottle contained water with ligand (capsaicin or mustard oil) and 
the other bottle contained normal water.  Mice were tested over three days and separate groups of 
male and female WT and ART-OE mice were used for the capsaicin and mustard oil tests 
(Figure 21).  As predicted from the changes in TRPV1 and TRPA1 gene expression, both male 
and female ART-OE mice drank significantly smaller volumes of capsaicin containing water 
(Males: WT 1.57 ± 0.09 ml; ART-OE 1.00 ± 0.07 ml; p≤0.005; Females: WT 1.72 ± 0.11 ml; 
ART-OE 0.98 ± 0.04; p≤0.005) and mustard oil containing water (Males: WT 1.47 ± 0.14 ml; 
ART-OE 1.11 ± 0.06 ml; p≤0.05:; Females: WT 1.68 ± 0.10 ml; ART-OE 1.16 ± 0.06; p≤0.005) 
than WT mice (Figure 21A and C).  A similar hypersensitivity was seen when these volumes 
were calculated as a percentage of total water consumed (Capsaicin: Males: WT 29.08 ± 1.37 %; 
ART-OE 22.16 ± 1.26%; p≤0.005; Females: WT 28.87 ± 19.74 %; ART-OE 19.74 ± 0.79 %; 
p≤0.005), (Mustard Oil: Males: WT 26.86 ± 2.09 %; ART-OE 24.10 ± 1.70 %; p=0.160; 
Females: WT 31.15 ± 2.47 %, ART-OE 22.69 ± 1.58 %; p≤0.005) (Figure 21 B and D).  
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However, as a percentage, male ART-OE mice did not drink significantly less mustard oil than 
WT mice (above, p=0.160).  This reflects a curious property of the ART-OE male mice that 
drank significantly less total fluid whenever mustard oil was present (Males: WT: 5.29 ± 0.18 
ml, ART-OE: 4.52 ± 0.20 ml; p≤0.005; Females: WT: 5.47 ± 0.16 ml, ART-OE: 5.19 ± 0.17 ml; 
p=0.125).  Thus, male ART-OE mice were hypersensitive to the mustard oil as indicated by the 
decreased volume of mustard oil.  However, because the male ART-OE stopped drinking water 
altogether, they mask the difference in percentage. 
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Figure 21.  ART-OE mice display oral sensitivity to capsaicin and mustard oil 
Ten WT (blue) and 10 ART-OE mice (red) of both genders (40 mice total) were tested for oral sensitivity to the 
capsaicin and mustard oil using a two bottle drinking aversion test.  Mice given free access to the bottles, one of 
which contained ligand water and the other which contained normal water. A)  Both male and female ART-OE 
drank a decreased volume of capsaicin containing water than WT mice.  B) Same as A but calculated as a 
percentage of total water consumed.  C)  Both male and female ART-OE drank a decreased volume of mustard oil 
containing water than WT mice.  D)  Calculated as a percentage, female ART-OE mice drank less mustard oil 
containing water, but male ART-OE mice did not drink significantly less as a percentage of total water.  Mean ± 
SEM. *P<0.05 vs WT. 
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5.0  CALCIUM IMAGING RESULTS 
To determine if individual sensory neurons from the ART-OE mice were functionally 
sensitized to the ligands for TRPV1 and TRPA1, as suggested in the drinking behavioral 
experiments, calcium imaging studies of dissociated trigeminal neurons that were back-labeled 
from the tongue were performed.   In these experiments, the number and magnitude of responses 
to 1μM capsaicin and 100μM mustard oil were determined in trigeminal and backlabeled lingual 
afferents. 
5.1 MUSTARD OIL RESPONSES IN TRIGEMINAL NEURONS (NON-BACK-
LABELED NEURONS) 
In response to application of mustard oil, ART-OE mice had more mustard oil responsive 
trigeminal neurons than WT mice (WT 28% ± 8; ART-OE 42 ± 2; p≤0.05; WT n=5; ART-OE 
n=6; WT m.o. responsive cells 31; ART m.o. responsive cells 53) (Figure 22A).  In addition, in 
response to mustard oil, trigeminal neurons from the ART-OE mice had calcium transients of 
larger magnitude (Farea) than WT mice (WT 12.24 ± 2.06, ART-OE 32.67 ± 6.01; P=0.007) 
(Figure 23A).  These results suggest that trigeminal neurons from ART-OE mice have more 
mustard oil responsive cells and the responses are larger as indicated by the increased area of the 
calcium transients. 
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 Figure 22. Trigeminal and Lingual Afferent Calcium Responses to Mustard Oil and Capsaicin 
A) Percentage of trigeminal neurons (left) and WGA-backlabeled lingual neurons (right) that responded to 
application of 100µM mustard oil.  ART-OE mice (red) had a larger percentage of trigeminal neurons that 
responded to mustard oil (53 responsive cells of 126 total cells, n=6) compared to WT mice (blue) (31 responsive 
cells of 109 total cells, n=5).  A similar trend towards increased percentage of mustard oil-responsive neurons was 
seen in lingual afferents from the ART-OE mouse (WT: 8 of 17, n=5; ART-OE: 12 of 21, n=6).  B) Percentage of 
trigeminal neurons and WGA-backlabeled lingual neurons that responded to application of 1µM capsaicin.  There 
was no difference in the percentage of trigeminal neurons that responded to capsaicin oil between WT and ART-OE 
mice (WT: 65 responsive cells of 152 total cells, n=10; ART-OE: 85 responsive cells of 196 total cells, n=11).  
However in the lingual afferents from ART-OE mice, there was a trend towards an increased percentage of 
capsaicin-responsive neurons (WT: 12 of 26, n=9; ART-OE: 23 of 40, n=12).  Mean ± SEM. *P<0.05 vs WT. 
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Figure 23. Magnitude of Calcium Responses to Mustard Oil and Capsaicin in Trigeminal and Lingual 
Afferents 
A) Magnitude of response (Farea) of trigeminal neurons (left) and WGA-backlabeled lingual neurons (right) that 
responded to application of 100µM mustard oil.  Trigeminal neurons from ART-OE mice (red) had larger responses 
to mustard oil (n=46) compared to WT mice (blue) (n=27).  A similar trend towards increased magnitude of mustard 
oil response was seen in lingual afferents from the ART-OE mouse (WT: n=8; ART-OE: n=9; p=0.13).  B) 
Magnitude of response (Farea) of trigeminal neurons and WGA-backlabeled lingual neurons to application of 1µM 
capsaicin. Trigeminal neurons from ART-OE mice had a larger response to capsaicin (n=64) compared to WT mice 
(blue) (n=46).  In addition, lingual afferents from ART-OE mice had a larger calcium response to capsaicin (n=11) 
compared to WT mice (n=7).  Mean ± SEM. *P<0.05 vs WT. 
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5.2 CAPSAICIN RESPONSES IN TRIGEMINAL NEURONS (NON-BACK-
LABELED NEURONS) 
In contrast to mustard oil, the number of responsive trigeminal neurons to application of 
capsaicin was not different in the ART-OE mice compared to the WT mice (WT 41 ± 3; ART-
OE 48 ± 6; p=0.17; WT n=10; ART-OE n=11; WT cap responsive cells 65; ART cap responsive 
cells 85) (Figure 22B).  However, trigeminal neurons that responded to capsaicin in the ART-OE 
mice had larger Farea than WT mice (WT 54 ± 9; ART-OE 79 ± 10; P=0.04) (Figure 23B).  These 
results suggest that trigeminal ganglia from ART-OE mice do not have more capsaicin 
responsive neurons but that the capsaicin responsive neurons present exhibit larger calcium 
transients.  This functional result may reflect the increase in TRPV1 mRNA but not an increase 
in percentage of TRPV1-positive neurons seen in the ART-OE. 
5.3 LINGUAL AFFERENTS FROM ART-OE MICE APPEAR TO BE SENSITIZED 
TO CAPSAICIN AND MUSTARD OIL 
Calcium imaging from WGA-backlabeled lingual afferents showed that there were trends 
towards increased percentages of capsaicin (WT 46%; ART-OE 58%) and mustard oil 
responsive cells (WT 47%; ART-OE 57%) in the ART-OE mice.  In addition, the magnitude of 
response in lingual afferents to capsaicin was increased (Area: WT 51 ± 16; ART-OE 128 ±25; 
p=0.02) (Figure 23B).   Application of mustard oil also produced a trend toward increased 
calcium flux in lingual afferents from the ART-OE animals (Area: WT 50 ± 11; ART-OE 81 ± 
23; p=0.13) (Figure 23A).  In addition, compared to the general trigeminal afferents, there were a 
greater number of lingual afferents that responded to capsaicin or mustard in both genotypes, 
indicating that the tongue is uniquely designed to detect these noxious chemicals.  Taken 
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together, these imaging results support our hypothesis that lingual afferents in the ART-OE 
mouse are hypersensitive to capsaicin and mustard oil and convey at least a portion of the 
behavioral sensitivity observed in the drinking tests. 
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6.0  DISCUSSION 
6.1 ANATOMY: SURVIVAL EFFECTS OF ARTEMIN 
Our results indicate that transgene-driven overexpression of artemin in skin and tongue 
keratinocytes enhances developmental survival and functional properties of a unique 
subpopulation of sensory neurons that are GFRα3-, TRPV1-, and TRPA1-positive.  The in vivo 
survival effect seen in the ART-OE mice is consistent with in vitro studies showing increased 
survival of postnatal sensory neurons cultured with artemin (Baloh et al., 1998b; Baudet et al., 
2000).  It is somewhat surprising, then, that adult GFRα3-/- mice have normal numbers of DRG 
and TG neurons and adult ART-/- mice have no apparent differences in density of CGRP-
positive or IB4-binding DRG neurons and have normal GFRα3-positive fiber innervation 
patterns in whole mount E14.5 embryos (Nishino et al., 1999; Honma et al., 2002).   The artemin 
independent survival of GFRα3-positive afferents seen in the mice lacking artemin and the 
apparent GFRα3-independent survival of sensory neurons in the GFRα3-/- may reflect 
overlapping GFL dependencies during development.  GDNF or neuturin may support survival of 
these neurons by binding GFRα3, GFRα1 or GFRα2 since there may be overlapping GFRα 
receptor expression early in development (Baudet et al., 2000) and there is some evidence that 
GDNF family ligands may be promiscuous in their receptor selectivies (Baloh et al., 1998b).  
NGF signaling through TrkA, which is also expressed in GFRα3 neurons (Orozco et al., 2001), 
may also have promoted survival.  However, in the ART-/- studies, actual counts of sensory 
neurons were not reported and sensory projections in postnatal mice were not examined, so there 
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still could be small losses in sensory neuron numbers or defects in sensory innervation patterns 
in these mice. 
6.2 ANATOMY: GFRΑ3 AND TRPV1 IMMUNOLABELING 
In newborn mice, GFRα3 mRNA is expressed robustly in 20-34% of sensory ganglia 
neurons, mostly in small and intermediate diameter neurons (Naveilhan et al., 1998; Baudet et 
al., 2000).  In adult mouse, 19-20% of DRG neurons express GFRα3 (Orozco et al., 2001), 
supporting a role for artemin in adult systems and during development.  In our study, 
overexpression of artemin in the skin caused a 20.5% increase in neuron number in the DRG of 
adult mice.  Based on immunolabeling studies, a portion of this increase likely reflects addition 
of small to intermediate diameter GFRα3-positive neurons that project to dermal and epidermal 
compartments of skin.  However, while there was clearly an increase in total number of GFRα3-
positive neurons, no difference in percentage was detected between the WT and ART-OE mice 
in GFRα3 total cell counts.  An increase in percentage of GFRα3-positive neurons would be 
expected if all of the increase in cell number in the ART-OE mouse (20.5%) was from GFRα3-
positive neurons.  This raises a number of possibilities.  First, artemin may be promoting the 
survival of neurturin or GDNF-responsive neurons that express GFRα3 early in development.  
Second, some artemin responsive cells may downregulate expression of GFRα3 in the adult to 
concentrations below the detection level of our GFRα3 antibody.   
Our studies also show that both the skin and the tongue are hyperinnervated by GFRα3-
positive fibers and that the somal size of GFRα3-positive afferents is increased nearly 30% in the 
ART-OE.   Thus, in addition to an increased number of GFRα3-positive afferents innervating the 
skin and tongue, increased branching causing hypertrophy of the neuronal soma may also 
contribute to the functional results observed in our study.  
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Since a previous report indicated that nearly all GFRα3-positive neurons were also 
TRPV1-positive, we confirmed this result in our study.  In the DRG, over 95% of neurons that 
were GFRα3-positive were also TRPV1-positive in both WT and ART-OE mice.  However, 
immunolabeling in the skin showed that in WT mice TRPV1 was only detected at low levels in a 
few of the GFRα3-positive fibers.  However, in the ART-OE skin nearly all GFRα3-positive 
fibers displayed high intensity TRPV1 labeling.  This increase in GFRα3/TRPV1-afferent 
colabeling likely reflects enhanced expression of TRPV1 protein and is consistent with the 
elevation of TRPV1 mRNA and somal hypertrophy of TRPV1-positive neurons in the ART-OE. 
6.3 ANATOMY: LINGUAL AFFERENTS 
One concern with these anatomical results is that DRG and TG are heterogenous 
populations of afferents that project to many target tissues.  To confirm that the changes in gene 
expression and immunolabeling for GFRα3 and TRPV1 occurred in keratinized tissues, we 
performed retrograde labeling from the tongue, a site of transgene expression.  These studies 
showed that there were a larger percentage of TRPV1 and GFRα3-positive afferents innervating 
target tissues overexpressing artemin. Furthermore, electron microscopy of lingual nerve 
segments showed that nerves from ART-OE mice were enlarged and contained hypertrophied 
unmyelinated and myelinated fibers (although hypertrophy was less pronounced in the 
myelinated fibers).   Thus, the increase in size of lingual nerve segments likely resulted from a 
combination of fiber hypertrophy and increased number of GFRα3-positive fibers, further 
confirming that afferents innervating the tongue were responsive to artemin. 
 
In addition, our results from WT mice in the backlabeling studies suggests that lingual 
afferents are similar to cutaneous afferents in TRPV1 expression, but dissimilar in that most 
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lingual afferents are IB4-negative and many are CGRP-positive (Christianson et al., 2006).  
Interestingly, IB4-binding and overlap between TRPV1 and IB4 was increased in the ART-OE, 
suggesting that artemin may promote the survival of TRPV1/IB4-positive afferents or upregulate 
the sugar residues that IB4 binds.  We have previously found that IB4 binding increases 
following CFA injection (C.M Elitt, unpublished observations) and nerve injury (H.R. Koerber, 
unpublished observations).  Since artemin is upregulated following inflammation and injury 
(Baloh et al., 1998b; Malin et al., 2006), it is possible that the increase in IB4-binding in the 
back-labeled lingual afferents in the ART-OE mice result from the increased concentration of 
artemin in the tongue.  
6.4 ANATOMY: ARTEMIN REGULATION OF TRPA1 
One of the most striking findings of our anatomical characterization of the ART-OE mice 
was the robust increase in expression of TRPA1 mRNA in both the DRG and TG.  
Immunolabeling showed that many of the TRPA1-positive neurons were also GFRα3-positive.  
TRPA1 mRNA has previously been shown to be present in a subpopulation of TRPV1-positive 
neurons (Story et al., 2003), and since TRPV1 is present in nearly all GFRα3-positive afferents, 
it is not surprising that nearly all of the GFRα3-positive afferents in our study were TRPA1-
positive.  TRPA1 protein and mRNA expression was present in a large number of neurons in 
both DRG and TG as evidenced by a large number of TRPA1-immunolabeled neurons and low 
Ct values (similar to TRPV1 Ct values) in our RT-PCR assays.  There is widespread 
disagreement about the number of TRPA1-positive afferents in the literature ranging from very 
small percentages (4%) (Story et al., 2003) in mouse to much larger distributions in rat (32-38%) 
(Obata et al., 2005; Katsura et al., 2006c) and mouse (20-57%)  (Jordt et al., 2004; Nagata et al., 
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2005).  Our results agree with a wider distribution and suggest that neurons expressing low levels 
of TRPA1 may dramatically increase their expression in response to artemin. 
It is highly significant that all GFRα3-positive neurons also express TRPV1 and TRPA1 
because it suggests that artemin supports nociceptor neurons that respond to various stimuli such 
as heat, cold, capsaicin and mustard oil.  Behavioral studies and calcium imaging experiments 
support this functional role of artemin.    
6.5 BEHAVIORAL RESPONSES TO HEAT  
Previous studies have shown that TRPV1 is required for heat hypersensitivity during 
inflammation (Caterina et al., 2000; Davis et al., 2000).  NGF upregulates TRPV1 mRNA and 
protein expression during inflammation (Ji et al., 2002; Amaya et al., 2003) and blocking 
increases in NGF expression with anti-NGF antibodies alleviates the hypersensitivity to noxious 
heat in inflammatory pain models (Ji et al., 2002).  Our behavioral studies show that 
overexpression of artemin produces hypersensitivity to noxious heat applied to the skin, 
supporting the hypothesis that, like NGF, artemin regulates TRPV1 expression and function.  
The role of artemin in promoting sensitivity to noxious heat is further strengthened by 
intracellular recording data in an ex vivo preparation showing that C-fibers from ART-OE mice 
have reduced heat thresholds and increased firing frequencies in response to a heat ramp applied 
to the skin (Elitt et al., 2006).   Interestingly, C-fiber afferents in mice that overexpress NGF in 
the skin exhibited increased firing frequencies but had unchanged heat thresholds and did not 
have increases in TRPV1 mRNA (Stucky et al., 1999; Molliver et al., 2005), suggesting that 
findings in the ART-OE mice are unique.  Furthermore, artemin mRNA increases dramatically in 
the skin during inflammation, even more than NGF (Malin et al., 2006).  Therefore, the increased 
expression and/or sensitization of TRPV1 in GFRα3-positive neurons observed in the ART-OE 
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mouse suggests that artemin may play a key role in modulating afferent thermal sensitivity to 
heat during inflammation.  
Behavioral responses to injection of the TRPV1 agonist, capsaicin, in the ART-OE 
mouse further support the role of artemin in modulating TRPV1 expression and function.  Both 
WT and ART-OE mice displayed increased sensitivity to heat following capsaicin injection and 
percentage decrease in withdrawal latencies from baseline were similar in both genotypes.  This 
observation that ART-OE mice, despite already being sensitized to heat relative to WT mice at 
baseline, were still able to become further sensitized to heat following capsaicin injection 
suggests that sensitization of TRPV1 was not maximal in the ART-OE.  (A similar result was 
observed when a more general inflammant, CFA, was injected into the hindpaw).  In addition, 
application of the TRPV1 agonist, capsaicin, to dissociated DRG neurons from ART-OE mice 
showed that the number of responsive cells and the magnitude of responses were increased in 
ART-OE animals (Elitt et al., 2006).  Given that acute artemin can also potentiate capsaicin 
responses in dissociated WT neurons (Malin et al., 2006), our behavioral sensitivity to capsaicin 
and heat likely reflect a combination of increased number of TRPV1-positive afferents, increased 
expression of TRPV1 in individual afferents and increased sensitivity of the TRPV1 channel.  
6.6 MUSTARD OIL BEHAVIOR 
Our behavioral studies also suggest that artemin upregulation of TRPA1 leads to 
behavioral sensitivity to mustard oil applied topically to the mouse hindpaw.  The two studies of 
mice with disruption in the pore region of TRPA1 suggest that TRPA1 is certainly one of, if not 
the only, mustard oil receptor (Bautista et al., 2006; Kwan et al., 2006).  Kwan et al. showed a 
substantially reduced number of mustard oil-responsive cells and reduced behavioral sensitivity 
to oral or injected mustard oil, whereas Bautista et al. show the complete absence of mustard oil 
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responses behaviorally or in dissociated cells.  Of note is that the binding site for mustard oil is 
still present in the knockout construct and presumably expressed in the TRPA1-/- mice, raising 
the possibility that mustard oil binding alone may transduce a portion of the mustard oil response 
in the Kwan TRPA1 -/- mice.  Regardless, the majority of the mustard oil response is conveyed 
via TRPA1, suggesting that TRPA1 mediates the increased sensitivity to mustard oil seen in our 
study. 
These studies also showed dramatic differences in nocifensive responses and resulting 
edema in male versus female mice.  Male mice of both genotypes displayed much more edema 
and lengthier and more abundant nocifensive behavior.  There was no difference in TRPA1 
mRNA expression between male and female mice of either genotype (data not shown), 
suggesting that the abundance of TRPA1 is unlikely to account for this difference (although 
protein expression could still be different).  Other endogenous inflammatory mediators that are 
known to sensitize TRPA1, such as bradykinin (Bandell et al., 2004) may be differentially 
regulated in female and male mice during inflammation and could account for this behavioral 
difference.   Estrogen and androgen receptors are present on small diameter DRG neurons 
(Sohrabji et al., 1994; Papka et al., 1997; Keast and Gleeson, 1998) and therefore sex hormones 
may modulate the response of TRPA1 to mustard oil.  While the exact mechanism is unknown at 
this point, there is a clear gender difference in the response to topical application of mustard oil. 
6.7 ROLE OF TRPA1 IN COLD BEHAVIOR 
In addition to hypersensitivity to mustard oil, ART-OE mice also display hypersensitivity 
to noxious cold applied to the hindpaw.   The role of TRPA1 in cold detection remains highly 
controversial.  Our results suggest that TRPA1 is present in most GFRα3-positive neurons and 
therefore increases in TRPA1 protein expression or function could mediate the hypersensitivity 
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to noxious cold seen in these studies.  In heterologous systems, TRPA1 is directly activated by 
noxious cold stimuli (Story et al., 2003; Bandell et al., 2004), but in dissociated neurons 
activation of TRPA1 by noxious cold is more difficult.  Responses in dissociated DRG neurons 
can be delayed for up to a 1 min following application of noxious (12°C) cold (Reid, 2005), 
suggesting the possibility that cold activation of TRPA1 in native neurons is actively inhibited 
and may require a lengthy stimulus for activation.  It is not surprising then that response latencies 
to noxious cold applied to the hindpaw in the ice block test were delayed, taking nearly 30 
seconds in WT mice and 16 seconds in ART-OE mice for the first response.  Thus, cold 
responses may be very different than heat responses and require stimuli of longer and more 
intense duration.   
In an attempt to clarify the role of TRPA1 in cold detection, two groups disrupted the 
TRPA1 gene (Bautista et al., 2006; Kwan et al., 2006).    Bautista et al. found no difference in 
latency to hindpaw lift on a cold plate (0°C) and no difference in flinches/min in the acetone test 
between wildtype and TRPA1-/- mice.  However, Kwan et al found decreases in the number of 
hindpaw lifts over five minutes in the cold plate test (0°C) (particularly in female mice) and 
decreased duration of paw shake in the acetone test.  These studies suggest that the method of 
measuring responses and the gender of the mice used may also be critical in testing noxious cold 
behavior.  Our results from three different types of cold tests in mice of both genders indicate 
that the ART-OE mice are sensitized to noxious cold supporting a role for TRPA1 in detecting 
noxious cold stimuli. 
Few studies have examined the electrophysiological properties of nociceptors that 
respond to noxious cold.  The limited studies have used widely varying applications of noxious 
cold stimuli and therefore produced varying results.  For example, in monkey, 78% of Aδ and C-
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nociceptors were excited by ice applied to their receptive fields (LaMotte and Thalhammer, 
1982).  In the rat hindpaw, 10% of Aδ and 8% of C-nociceptors were excited by cold stimuli at 
12°C (Leem et al., 1993).  A more comprehensive study examining stimulus response functions 
for cutaneous nociceptors (saphenous nerve) over a wide range of controlled cold stimulus 
temperatures, found that all Aδ nociceptors were sensitive to noxious cold applied with a Peltier 
device (2°C steps, 10 second application) with response thresholds that varied from 14 to -18°C 
(mean -4.6°C) (Simone and Kajander, 1997).  The same group examined C-fibers and found that 
all responded to noxious cold (range 12°C to -6°C, mean 3°C) (Simone and Kajander, 1996).  
These studies suggest that there are many noxious cold cutaneous nociceptors but temperature 
and duration of stimulation are critical for their detection.  While the temperature of the hindpaw 
skin in our behavioral tests was not directly measured, it was likely near 0°C, as there was little 
melting of the ice block and hindpaws maintained nearly constant contact with the ice.  Thus, our 
results may be explained by activation of cutaneous nociceptors. 
Some evidence suggests that responses to noxious cold applied to the skin may be due to 
nociceptors innervating veins (Fruhstorfer and Lindblom, 1983; Klement and Arndt, 1992).  We 
cannot rule this out as a possible mechanism for the behavioral sensitivity to cold observed in our 
studies.  It is also possible that a combination of both nociceptors innervating skin and those 
innervating deeper structures could mediate the responses to noxious cold.  
6.8 ORAL BEHAVIOR 
Drinking aversion testing in the ART-OE mice also confirmed that these mice were 
hypersensitive to mustard oil and capsaicin, the ligands for TRPA1 and TRPV1.  The role of 
lingual afferents in pain detection has not been extensively studied despite the prevalence of 
chronic oral pain conditions.  Interestingly, one treatment that is effective for oral pain (Burning 
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Mouth Pain, in particular) is a capsaicin containing oral rinse (Epstein and Marcoe, 1994).  Our 
results suggest that artemin responsive, TRPA1-, TRPV1-positive afferents may mediate some of 
the hypersensitivities seen in oral pain disorders.  It would be extremely interesting to measure 
artemin concentrations from tongue biopsies of patients with burning mouth syndrome. 
One concern with our drinking experiments is that geniculate neurons in taste cells of the 
tongue might be contributing to the hypersensitivity seen in the ART-OE mouse.  A very recent 
report demonstrates that TRPV1 mRNA and TRPA1 mRNA are expressed by geniculate 
ganglion neurons in rats (Katsura et al., 2006a), contradicting an earlier study in mouse that 
showed TRPV1 mRNA was not expressed in geniculate neurons (Matsumoto et al., 2001).  It is 
unknown if GFRα3 is expressed in geniculate neurons so it is difficult to known if geniculate 
neurons are contributing to a portion of our findings of hypersensitivity in the ART-OE animals.  
Future experiments examining GFRα3 and TRPV1 immunolabeling of geniculate ganglia from 
WT and ART-OE mice will likely provide some clues about the contribution of geniculate 
neurons to our findings.   
6.9 CALCIUM IMAGING STUDIES 
Calcium imaging studies of both trigeminal and lingual afferents generally support our 
cutaneous and lingual behavioral and anatomical results.  Although our cell numbers are 
relatively small, there were trends that indicated more lingual afferents responded to mustard oil 
and capsaicin and increases in the magnitudes of the responses to these ligands.  The apparent 
increase in number of responses further support the hypothesis that artemin increases the number 
of TRPV1/TRPA1-positive afferents innervating the tongue, as observed for TRPV1 in our back-
labeling anatomical studies.  The increased magnitude of response to capsaicin and mustard oil 
suggests that artemin increases expression or sensitivity of these channels in individual neurons.  
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In addition, the percentage of lingual afferents that responded to capsaicin in the calcium 
imaging studies was also greater than the TRPV1-immunolabeled percentage in our backlabeling 
experiments (WT immunonlabeling for TRPV1=25%, calcium imaging=47% of cells were 
capsaicin responsive; ART-OE immunolabeling TRPV1=42%, calcium imaging=58%).  This 
likely reflects increased sensitivity of functional assays such as Ca++ imaging compared to 
immunocytochemical detection of protein by antibody visualization (Breese et al., 2005; Malin et 
al., 2006).  Finally, in general, there were also more capsaicin and mustard oil sensitive lingual 
afferents than trigeminal afferents that responded to responded to these chemicals in both WT 
and ART-OE mice.  This suggests that lingual afferents may be uniquely designed to sense 
noxious thermal and chemical stimuli. 
 Findings in non-lingual trigeminal afferents for mustard oil were similar to findings in 
the lingual afferent population, except that the number of responses and magnitude of responses 
were generally smaller in a given genotype.  These mustard oil responses support a functional 
role for the increase in TRPA1 mRNA in the trigeminal ganglia and complement findings in 
DRG neurons where both the number and magnitude of mustard oil responses were increased in 
ART-OE neurons (S.A. Malin, unpublished observations).  In contrast to findings in lingual 
afferents and DRG neurons, the number of capsaicin responsive trigeminal neurons was not 
different in the ART-OE.  However, the magnitude of response in capsaicin sensitive neurons 
appeared to be larger in trigeminal neurons.  This suggests that trigeminal neurons were 
sensitized by artemin but differences in number of responses were not readily apparent.  
Therefore, increases in TRPV1-positive neurons in the trigeminal ganglia may be in select 
populations of afferents, such as the lingual population, that are hidden in the overall trigeminal 
population.  
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6.10 BROADER ISSUES AND FUTURE EXPERIMENTS 
Since artemin is expressed beginning in early development (E11) and maintained 
throughout adulthood, one concern with experiments in the ART-OE mouse (and transgenic 
animals in general) is that compensation for chronically increased artemin may occur, thereby 
calling into question the biological relevance of these mice.  While there is some validity to this 
argument, these mice have provided information critical about artemin regulation of TRPA1 and 
TRPV1 expression and function that would otherwise have been missed.  In addition, parallel 
work in our laboratory studying the acute effects of artemin has complemented the findings in 
the ART-OE mouse.  For example, a single injection of artemin into the mouse hindpaw 
produces thermal hyperalgesia lasting for hours and in combination with NGF lasting for 7 days 
(Malin et al., 2006), supporting the idea that artemin can robustly sensitize nociceptors as seen in 
the ART-OE mouse.  In addition, application of artemin to dissociated DRG neurons potentiates 
capsaicin responses and the potentiation is larger than that seen with other GDNF family 
members or NGF (Malin et al., 2006), further supporting our findings that artemin can regulate 
TRPV1 function.  Future experiments will also address whether application of artemin to 
dissociated sensory neurons leads to upregulation of TRPV1 mRNA and TRPA1 mRNA as seen 
in the ART-OE mouse and if mustard oil or cold responses can be potentiated by acute 
application of artemin to dissociated neurons. 
As discussed earlier, artemin increases dramatically following CFA-induced 
inflammation (5-fold more than NGF) (Malin et al., 2006) and is also upregulated in the distal 
nerve segment following sciatic nerve transaction (Baloh et al., 1998b).   TRPA1 also increases 
following CFA-induced inflammation in rats (Obata et al., 2005) and the same is true in mouse 
where TRPA1 increases nearly 4 fold in lumbar DRGs following CFA injection (unpublished 
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observations, S.A. Malin).  Given our findings in the ART-OE mouse (increased TRPA1, cold 
hypersensitivity), it is intriguing to speculate that artemin may mediate a large portion of the 
increase in TRPA1 seen during injury or inflammation, thereby contributing to cold hyperalgesia 
seen in these models.  Future experiments using TRPA1 siRNA in the ART-OE mouse or 
crossing in TRPA1 KO mice with the ART-OE mice will provide critical insights into the 
validity of this conjecture.   
In summary, our results demonstrate that artemin promotes survival and modulates 
functional properties of a select population of TRPV1- and TRPA1-positive nociceptors critical 
for the detection of noxious thermal and chemical stimuli.  Increases in artemin concentrations in 
the skin or tongue during inflammatory or neuropathic pain conditions may play a role in 
initiating the hypersensitivities to heat and cold observed in these types of chronic pain.  Based 
on our studies, targeted interventions to minimize increases in artemin or the channels it 
upregulates, TRPV1 and TRPA1, may produce novel therapeutics for patients with chronic pain.   
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